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Seafood is one of the most common food items that cause food 
allergy. It is found that tropomyosin of seafood is one of the major food 
allergens in human diet. Despite years of investigation, the physiological 
mechanisms involved in food allergy are poorly understood. A number of 
animal models have been developed to investigate the molecular 
mechanisms of food allergy and to characterize allergenic potential of novel 
proteins. In this study, purified recombinant protein of the shrimp 
tropomyosin was used to feed mice by oral gavage. The goal is to develop 
a mouse model that closely mimics the human hypersensitive responses in 
shrimp allergy. 
Shrimp (Metapenaeus ensis) tropomyosin from the clone in plasmid 
pGEX was available. The full length of tropomyosin gene was amplified 
by polymerase chain reaction (PGR). The PGR product was subcloned into 
a His-tag expression vector pQE-30 and transformed into E. coli for 
expression of recombinant protein. Recombinant tropomysoin was 
‘ purified by chromatography using Nickel-nitrilotriacetic acid column. 
i 
Three-week-old female Balb/C mice were fed weekly with 0.1 mg or 1 mg 
tropomyosin with cholera toxin as the adjuvant. Another group of mice 
were fed with 0.1 mg of tropomyosin without the adjuvant. Mice fed with 
PBS, His-tag protein, and lysozyme were used as control. Mice were 
challenged at the fourth week post immunization using 1 mg tropomyosin in 
all groups except the group of mice fed with 1 mg tropomyosin, which was 
challenged with 5 mg tropomyosin. 
Mice immunized with recombinant tropomyosin developed signs of 
allergic responses. These mice scratched around the snout, body and tail. 
The snouts of mice fed with tropomyosin swelled. Tropomyosin-specific 
IgE was induced significantly in mice fed with 0.1 mg tropomyosin with 
adjuvant. Tropomyosin-specific IgE level induced in other 
tropomyosin-feeding groups (1 mg tropomyosin with adjuvant and 0.1 mg 
tropomyosin without adjuvant) was not significantly higher than that in 
control mice. Sera from mice fed with 0.1 mg tropomyosin with adjuvant 
and 1 mg tropomyosin with adjuvant gave positive result in passive 
cutaneous anaphylaxis assay. Splenocytes proliferated significantly in vitro 
from mice fed with 0.1 mg tropomyosin with adjuvant, 1 mg tropomyosin 
with adjuvant and 0.1 mg tropomyosin alone. Production of IL-2 and IL-4 
by splenocytes re-stimulated with tropomyosin in vitro was significantly 
higher in mice fed with 0.1 mg tropomyosin and adjuvant than in control 
mice. IL-10 and IFN y level were not different among all groups. These 
findings suggested that mice exhibited Th2 cytokine responses. Mice fed 
‘ with 0.1 mg tropomyosin with adjuvant, 1 mg tropomyosin with adjuvant 
ii 
and 0.1 mg tropomyosin alone showed inflammation of small intestines 
from histological sections, while small-scale inflammation of small 
intestines were observed in some control mice. 
It is concluded that oral sensitization of mice with shrimp 
tropomyosin could elicit antigen specific humoral and cellular responses to 
the immunized food antigen. The mouse model would allow future 
intensive investigations on the molecular mechanisms involved in food 
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It is estimated that around 33% of anaphylactic reactions are caused 
by food (Hughes and Mills, 2001). Recent surveys revealed that food 
hypersensitivity occurs in 12-20% of the adult population (Young et al., 
1994; Altaian and Chiaramonte, 1996). In US, about 2% adult and 4-8% 
children suffer from different forms of food allergy (Burks and Sampson, 
1993). Approximately 100 Americans die each year as the direct result of 
food induced anaphylaxis. Among various food items, crustaceans have 
long been known to be a common cause of allergic reactions in human. In 
crustacean food allergy, shrimp allergies are most frequently reported. 
Despite years of intense investigation of food allergy, the 
immunopathogenesis of food allergy was not clearly understood. The only 
effective therapy to food allergy is the avoidance of direct contact of allergic 
food. 
Animal models have always been used in the investigation of human 
diseases. They allow researchers to investigate the mechanisms of the 
diseases and develop therapeutic strategies to treat the diseases. A number 
of animal models have been developed to investigate the physiological and 
molecular mechanisms of food allergy and to characterize allergenic 
potential of novel proteins. Mice, guinea pigs, rats, atopic dog, and pigs 
are animals commonly used in this field of study. Each of these animals 
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has its own advantages towards this kind of study. However, among them, 
mouse is a preferred choice for food allergy studies as its immune system is 
well understood. Apart from the strain of animal, the age of the animal, 
antigen dosage, use of adjuvant, and sensitization period are factors 
affecting the immune responses of the animals. Developing an appropriate 
animal model would be the key for success in this field of study. 
Tropomyosin has been identified as a major seafood allergen in 
crustaceans. This heat stable allergen has been identified, sequenced and 
cloned in the shrimp and other shellfish by different research groups. No 
attempt was made to apply tropomyosin in inducing hypersensitivity 
responses which mimic human food allergy responses in animals. Thus, in 
the present study, recombinant shrimp tropomyosin protein was produced to 
feed mice orally for the development of an animal model of shrimp allergy. 
The goal of this thesis research is to develop a mouse model that 
closely mimics human hypersensitive responses in shrimp allergy, which 
will allow future studies on the molecular mechanisms involved in food 
allergy and design of therapeutic modalities. The specific objectives of the 
present study are therefore to (1) establish a mouse model of allergic 
response to shrimp, and (2) determine the T cell response to shrimp in the 
mice. 




information of food allergy, mechanism and clinical symptoms of food 
allergy, basic information on the major shellfish allergen tropomyosin, the 
studies of food allergy using animal models and future approaches for 
treatment of food allergy. Chapters 3 and 4 present the studies on the 
cloning and expression of tropomyosin, and sensitization of mice to shrimp 





This chapter reviews the literature on (1) history and prevalence of 
food allergy; (2) mechanism and clinical symptoms of food allergy; (3) 
tropomyosin as a major shellfish allergen; (4) the use of animal model in the 
studies of food allergy; and (5) future approaches for the treatment of food 
allergy. 
2.1 History and prevalence of food allergy 
Food allergy refers to adverse reactions to food which involve the 
immune system. It is believed that most of the food allergies are caused 
type I hypersensitive response to food. It is the result of sensitization of 
food allergens in the gastrointestinal tract after ingestion of food. Type II 
food allergy is considered as allergic responses developed after inhalation of 
an airborne allergen that crossreacts with a specific food (Breiteneder and 
Ebner，2000). Both types of food allergy result in breakdown of oral 
tolerance and overproduction of food allergen-specific IgE antibody in the 
body. 
The concept of food allergy was developed in early human history. 
Woods (1986) stated that early clinical records of cow's milk and goat's 
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milk allergy were described by Hippocrates in 570-460 BC and Galen in 
130-219 AD, respectively. However, there was no experimental studies on 
allergy until the discovery by Charles Blackey (1820-1900). Blackley who 
suffered from severe allergic rhinitis, was a pioneer on allergy research in 
the early 1870s. He demonstrated that pollen was the immunogen causing 
hayfever. Blackley put fresh or dried pollen to his eyes, nose, skin and 
tongue, resulting in typical symptoms of rhinitis. He found that the 
severity of the rhinitis was directly proportional to the number of pollen 
applied. This is the first scientific investigation of allergens. In the 
beginning of the century, involvement of antibodies in the pathogenesis 
of food allergy was performed by Praiivsnitz and Kustner (1912). They 
performed a classical experiment by injecting serum from fish-allergic 
patient (KUstner) into the skin of a nonatopic individual (Praiisnitz). The 
injection site was then challenged with fish extract and allergic responses 
were observed. This study represents an early study on food allergy. 
Allergies are the sixth leading cause of chronic diseases and 
approximately 9-16% of people suffer from allergies in the United States 
(ISAAC, 1998). Treatment of allergies has a great economic impact in the 
United States, amounting $18 billion annually in health care cost (AAIA, 
1996-2001). At present, it is estimated that around 33% of anaphylactic 
reactions relate to food consumption (Hughes and Mills, 2001). Recent 
surveys reveal that food hypersensitivity occurs in 12-20% of the adult 
population (Jansen et al., 1994; Young et al., 1994; Altman and Chiaramonte, 
I * 
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1996). The death count from food allergies adds up to about 100 
Americans per year with most of them being children (ISAAC, 1998). 
Food allergy does not only affect a wide range of the population; the 
occurrence of food allergy appears to have a geographical distribution. 
Woods et al. (2001) stated that specific type of food allergy cases are 
reported more frequently in a particular region. For instance, the 
prevalence of food allergies is 4.6% in Spain and 19.1% in Australia. 
Independent survey by Hughes and Mills (2001) also pointed out that 
allergic reactions to fish and shellfish are more common in countries around 
the Mediterranean than Europe in general. Except the geographical 
differences, prevalence of food allergy is also affected by the major diets in 
each culture. Allergies to rice and soy are more common in Far East than 
in western countries (Woods et al., 2001). 
2. 2 Mechanism and clinical symptoms of food allergy 
Despite the numerous reports on allergic reactions related to food, 
the nature of food allergy remains uncertain until 1968 when WHO 
International Reference Centre for Immunoglobulin designated IgE as a new 
class of human immunoglobulin (Bennich et al., 1968). When food is 
ingested, it is first processed through the gastrointestinal tract which forms 
an extensive barrier to the external environment. The mucosal immune 
system associated with the gastrointestinal tract is proficient in inhibiting 
immune responses to non-dangerous antigens and mounting a rapid response 
f ) 
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to pathogens. However, about 2% of ingested food are still absorbed and 
transported throughout the body in an immunologically active form (Husby 
et al., 1987; Sampson, 1999). Food antigens are typically poor 
immunogens and induce a state of unresponsiveness (oral tolerance) and 
thus intact food antigens usually do not cause clinical symptoms because 
most individuals acquire tolerance. This unresponsiveness of immune 
reaction is believed to be due to T cell anergy, secretion of 
non-inflammatory cytokines IL-10 and IL-4 by dendritic cells, and secretion 
of transforming growth factor P by T regulatory cells (Hershberg and Mayer, 
2000; Mayer, 2000; Smith et al., 2000). 
Despite the phenomenon of oral tolerance, IgE-mediated reactions 
develop when food specific IgE antibodies residing on mast cells and 
basophils recognize and bind to circulating ingested food allergens and 
thus activating the cells to release a number of potent mediators and 
cytokines. The development of IgE-mediated hypersensitive reaction of 
food is a series of complex molecular and cellular interactions, involving 
food allergens, antigen presenting cells (APCs), T cells and B cells. 
Their relationships are briefly illustrated in Figure 2.1. After ingestion, 
food allergens are broken down into small fragments (10 - 20 amino acid 
sequences). Some of these small fragments are presented by the APCs 
in the context of MHC class II molecules to T cells since they are 
exogenous fragments. The binding of allergen / MHC class II complex 
to the complementary T cell receptor stimulates the T cells to proliferate 
< > 
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Figure 2.1 Mechanism of IgE-mediated seafood allergy. When food 
allergens are presented by the antigen presenting cells (APC), T helper (Th) 
cells are activated by the receptor MHC class II on APC. The activation 
results in production of allergen-specific IgE antibodies by B cells. IgE 
‘ antibodies then associate with the surface of the mast cells. Secondary 
contact of the food allergens causes the formation of cross-linkage between 
the antibodies and the allergens, resulting in the breakdown of the mast cells 
and release of chemical mediators, e.g. histamine, which cause various 
symptoms of IgE-mediated hypersensitivity. 
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and generates signals to promote an IgE response (Vercelli, 1995a, b). The 
exposure of antigen to T cells causes the activation of Th2 cells. Recent 
studies showed a combination of interleukin 4 (IL-4), IL-5, IL-10, and IL-13 
produced by a subset of CD4+ T cells, termed Th2 cells, are found in 
increased abundance in allergic individuals (Umetsu and DeKruyff, 1997). 
These cytokines take a major role in the allergic inflammatory responses. 
IL-4 and IL-13 secreted by CD4+ T cells enhance the induction of IgE 
synthesis in B cells, mast cell growth and recruitment of lymphocytes, mast 
cells and basophils to sites of inflammation. IL-5 enhances the growth and 
differentiation of eosinophils and B cells, and IL-10 enhances the growth 
differentiation of mast cells and inhibits the production of IFN-y. In 
addition, a high affinity Fc receptor specific for s heavy chains (FcsR2) is 
also expressed in B cells upon IL-4 production. FcsR2 provides 
co-stimulatory signal to stimulate T-B cells cooperation and generation of IgE 
plasma cells. 
The mast cell, IgE and its receptor network play an important role in 
regulating allergic reactions (Ochi et al., 2000; Pawankar, 2001 )• Activation 
of Th2 cells by cytokines result in production of the allergen-specific IgE. 
Individuals who are allergic to a particular antigen would have a large 
proportion of the allergen-specific IgE bound to mast cells. IgE antibodies 
bind to a high affinity Fc receptor specific for 8 heavy chains (FcsRI) that are 
expressed on mast cells, basophils and eosinophils. Each FcsRI molecule is 
composed of one a chain that mediates IgE binding, and one p and two y 
I » 
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chains that are responsible for signaling. The amino terminal extracellular 
portion of the FcsRI a chain consists of two Ig-like domains and constitutes 
the IgE binding site. The p chain of the FcsRI chains consists of a single 
immunoreceptor tyrosine-based activation motif (ITAM) in the carboxyl 
terminus and the two identical y chain, each containing one ITAM (Novak et 
al.，2001; Balnk et al.，2003). In contrast, in non-atopic individuals, the 
mast cells associated IgE is highly heterologous in antigen specificity. 
Re-exposure of specific allergens results in formation of IgE 
cross-bridge of IgE molecules to allergen in an allergic individual which 
triggers a series of immunological responses. This cross-linkage of IgE 
molecules is less likely to happen in non-atopic individuals. Upon IgE 
cross-linking of the FcsRI in atopic individuals, the Lyn tyrosine kinase 
phosphorylates the ITAM of the p and y chains of FcsRI. Syk tyrosine 
kinase is then recruited to the ITAMs of the y chain, and activated, thus 
phosphorylating other proteins in the signaling cascade (Wilson and Oliver, 
2002). The mast cells are degranulated. The effector functions of mast 
cells are mediated by soluble molecules released upon activation. The key 
mediators include (a) histamines, (b) granular proteins such as tryptase, 
chymase, carboxypeptidase A, cathepsin G and proteoglycans, such as 
heparin (Saarinen et al., 2001a), (c) lipid mediators such as prostaglandin 
D2 and leukotrienes that have a variety of effects on blood vessels, 
bronchial smooth muscle and leukocytes, and (d) cytokines including TNF, 
IL-1, IL-4, IL-5,11-6,11-13，MlP-la, MIP-ip (Royer et al., 2001; Saarinen 
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et al.，2001b) and a potent Th2 response inducer IL-25 (Ikeda et al.’ 2003). 
On the other hand, mast cell activation is also negatively regulated by cyclic 
adenosine monophosphate (cAMP). Activated cAMP activates protein 
kinase A which in turn inhibits mast cell degranulation. In addition, the 
FcsRI activation pathway is regulated by the inhibitory Fc receptor (Fc丫Rllb) 
which contains an immunoreceptor tyrosine-based inhibitory motif (ITIM). 
Phosphorylation of ITIM leads to the recruitment of tyrosine phosphatase 
Sh2 domain-containing inositol 5-phosphatase (SHIP) and inhibition of IgE 
mediated FcsRI signaling (Huber et al., 2002; Kalesnikoff et al., 2002). In 
addition to mast cells, FcsRI is also expressed in basophils and eosinophils. 
The ability of eosinophils to release granules is enhanced by IL-5 (Togawa 
et al., 2001). Activated eosinophils produce and release lipid mediators 
such as PAF, prostaglandins and leukotrienes (Falcone et a l , 2000; 
Kawakami and Galli, 2002; Piliponsky et al., 2002; Prussin and Metcalfe, 
2003), in a similar fashion as mast cells and basophils. 
Although it is generally agreed that allergy is caused by the 
development of allergen-specific Th2 cells in allergic individuals, this is a 
much simplified picture. Furthermore, the recent discovery of a different 
subset of CD4+ T regulatory (Tr) cells and the manifestation of cytokine 
(IL-10 and TGF-P) dependent suppression of inflammatory response by 
CD4+ CD25- (Tr) T cells and cytokine independent suppression by CD4+ 
CD25- T cells substantiate the hypothesis that Tr cells have a critical role in 
maintaining immune homeostasis in vivo (Levings et al. 2002; Curotto de 
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Lafaille and Lafaille, 2002). The exact mechanism of the Thl/Th2 
paradigm is not fully understood and is likely to be influenced by a number 
of genetic and environmental factors (Aebischer and Stadler, 1996). 
Food allergy is the most common cause of anaphylaxis (Yocum and 
Khan et al. 1994) and systemic anaphylaxis is the most dangerous of all 
allergic reactions. Any food protein can theoretically cause anaphylaxis 
but shellfish is particularly potent. Reactions invariably occur within 60 
minutes including nausea, vomiting, emesis, abdominal cramping, 
respiratory difficulties, low blood pressure, throat swelling, abdominal pain, 
vomiting and diarrhea, some of which may occur within minutes of 
ingestion. More severe reactions lead to asphyxia, vascular collapse, 
irregular heartbeat or myocardia infraction. The quantity of food requires 
to induce a reaction is dependent on patient sensitivity, potency of the food 
allergen and other unknown factors. Repeated ingestion of allergenic 
foods may lead to poor appetite, intermittent abdominal pain and 
malabsorption. Oral allergy syndrome which involves direct contact of 
allergenic food with oral mucosa results in itching and swelling of the lips, 
tongue, palate and throat. Dermatological reactions (e.g. flushing, urticaria, 
angioedema and atopic dermatitis) (Sampson, 1983; Sampson and 
McCaskill, 1985)，respiratory reactions (e.g. wheezing and rhinitis) and 
ocular reactions (conjunctivitis) (Waring et al. 1985; Daul et al. 1987) are 
also frequently found in patients with food allergies. Shellfish, peanut and 
nuts in particular may invoke a fatal reaction in microgram amounts. The 
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sensitivity of individual patients to food allergens may change with time. 
Some patients may have tolerated certain amount of a particular food 
without significant ill effects in the past, but nevertheless they may develop 
a severe reaction when they ingest a similar amount in the second time. 
One interesting form of anaphylaxis is the exercise-induced, food-specific 
anaphylaxis. These patients develop anaphylaxis if they exercise within 
2-4 hours of ingesting a food item that they are allergic to (Castells et al., 
2003). However, ingesting the same food without exercise does not elicit a 
reaction. Wheat has been found to be the most common cause of 
exercise-induced anaphylaxis, but shellfish can also cause such a problem. 
Not only exercises can induce food-specific anaphylaxis, Steensma (2003) 
reported a patient developed severe allergic reactions to shellfish after kissed 
‘ with another person who had just eaten some shellfish. Currently, the only 
therapy for food allergy is strict avoidance of the food that causes allergy. 
Chemicals including cromoglycate histamine receptor antagonists and 
ketotifen are not recommended as propholytic treatment of food allergy 
because of the conflict of their efficacy (Micallef, 1983; Sogn, 1986). 
2.3 Tropomyosin as a major shellfish allergen 
Among various food items, crustaceans such as shrimp, lobsters and 
crabs have long been known to be the most common allergic food (Haddad 
and Korotzer, 1972; Hoffman and Haddad, 1974). With the advances of 
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Shibasaki et al. 1989; Morikawa et al.，1990; Carrillo et al., 1991 and 1994). 
Most of the food allergy cases are reported after ingestion of allergenic food. 
However, some allergic patients do not only develop allergic reactions to 
ingested shrimp, but also develop urticaria after handling shrimp directly or 
wrapping containing shrimp or other crustaceans such as lobster or crab 
(Hoffman et al., 1981). Shrimp water or vapor from cooked shrimp was 
shown to be a source of allergens in susceptible individuals (Lehrer et al., 
1990). Such contacts present a threat of occupational allergy among 
seafood-processing workers (Cartier et al. 1984). Some patients even 
develop adverse reactions towards crustaceans in the absence of previous 
contact (Waring et al., 1985). Asero et al. (2002) reported one case of 
airborne, heat labile shrimp allergy. The patient developed severe asthma 
and rhinoconjunctivitis associated with eyelid angioedema when he entered 
into a room where shrimp was being cooked. However no allergic 
response appeared when he ate the shrimp, nor any other respiratory 
symptoms developed. Skin prick test of this patient showed strong 
reactivity results towards shrimps and crabs (mean wheal diameter >5 mm), 
but no positive results were found using other food or airborne allergens 
(including allergens from house dust mites). IgE antibody from sera of the 
patient reacted with raw shrimp extract at 40 and 94 kDa but not to cooked 
shrimp extract. The 94kDa shrimp allergen may correspond to 97kDa 
shrimp allergen (protein DF9) that causes occupational allergy in seafood 
processing industries described by Griffin et al. (2001). 
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Despite that a number of allergens have been identified from 
common food items, such as lactoglobulin, lactalbumin and casein from 
cow's milk and ovalbumin and ovomucoid from hen's egg in 1970-80s, the 
identity of various seafood allergens remained unknown until the early 90s. 
Hoffman et al. (1981) was the first group to report on the biochemical 
isolation of shrimp allergens. They isolated two shrimp allergens named 
as antigen I and antigen II by gel filtration method. Both allergens are 
glycoproteins. Antigen I had a molecular size of 21 kDa while antigen II 
had a molecular size of 34 kDa. Although both allergens are present in 
shrimp, antigen II was higher in quantity than antigen I and had stronger 
allergenicity towards human sera. Other similar findings were 
continuously reported since then. For instance, Nagpal et al. (1989) 
isolated two heat-stable shrimp allergens from the shrimp Pemeus indicus. 
The two allergens were designated as Sa-I and Sa-II with molecular size 8.2 
kDa and 34 kDa respectively. Based on results of protein electrophoresis, 
Sa-I was suggested to be part of Sa-II after thermal denaturation process. 
Sa-II was later named as Pen i 1 under standardization of allergen 
nomenclature. Daul et al. (1991) demonstrated that the allergen from the 
shrimp Penaeus aztecus was a protein of 36kDa in size. The shrimp 
allergen was designated as Pen a bd 36 kDa (Daul et a l , 1991) and later 
named as Pen a 1 (Daul et al., 1994). The similarity in molecular size 
from various reports on shrimp allergen led scientists to speculate that they 
are the same molecule. 
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The identity of shellfish allergens was not determined until in the 
1990s (Shanti et al., 1993，Leung et al., 1994). Numerous studies found 
that tropomyosin is the major allergen present in the shellfish. 
Tropomyosins are a family of proteins present in muscles and non-muscle 
cells of all animals and in association with troponin complex plays a central 
role in the actin-linked calcium regulatory system of muscle contraction 
(Smillie，1982). Different from most other globular allergens, it is an 
unique allergen with long, filamentous, coiled structure (Aalberse, 2000). 
Shanti et al. (1993) reported high (86%) amino acid sequence homology 
between the allergen Sa-II (also referred as Pen i 1) from Pemeus indicus 
and the muscle protein tropomyosin of the fruit fly Drosophila 
melanogaster. Leung et al. (1994) first reported the cloning of the major 
shrimp allergen from Metapenaeus ensis, called Met e 1，by screening a 
cDNA library of shrimp muscle with sera from patients with shellfish 
allergy. The cDNA of Met e 1 exhibits an open reading frame of 281 
amino acids, coding for a 34-kDa protein. This molecule has high homology 
to Drosophila tropomyosin. Another shrimp allergen, Pen a 1，was also 
identified in the same year from the shrimp Penaeus aztecus (Daul et al., 
1994). The identity of Pen a 1 as tropomyosin has subsequently been 
confirmed by molecular cloning and nucleotide sequence analysis (Reese et 
al., 1997). Comparison of the amino acid sequences of antigen II，Pen a 1 
and Met e 1 shows that they are similar or identical allergens. The identity 
of tropomyosin as allergen in seafood has subsequently been confirmed in 
other crustaceans. Leung et al. (1998a, b) identified the allergen Pan s 1 
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from the spiny lobster Panulirus stimpsoni, Horn a 1 from the American 
lobster Homarus americanus, and Cha f 1 from the crab Charybdis feriatus. 
They have similar molecular weight (34 kDa) and their deduced amino acid 
sequences are highly homologous to shrimp tropomyosin. While Cha f 1 
appears to be slow muscle tropomyosin, the other crustacean allergens 
identified (Met e 1, Pen a 1, Horn a 1 and Pan s 1) are possibly fast muscle 
tropomyosins. 
While troposmyosin is the major allergen among crustaceans, there 
have been reports on the presence of other allergens in crustaceans (Lehrer 
et al., 1985; Lehrer 1986; also see p. 13). Yu et al. (2003) recently 
identified a novel allergen designated as Pen m 2 from the shrimp Penaeus 
monodon by two-dimensional immunoblotting using sera from patients with 
shrimp allergy. The allergen was cloned and the cDNA contained 1071 bp 
of open reading frame encoding a 356 amino acid protein with a theoretical 
molecular weight of 39.9 kDa. The sequence of this protein showed high 
similarity (close to 90%) to arginine kinase of shrimp {Penaeus japonicus), 
lobster {Homarus gammarus), and crawfish (Procambarus clarkii). Pen m 
2 exhibited arginine kinase activity and reacted with IgE from shrimp 
allergic patients. Strong reactivity of purified arginine kinase from shrimp 
{Metapenaeus ensis\ lobster {Homarus gammarus), crawfish 
{Metanephrops thomsoni), and crab {Scylla serrata) with anti-Pen m 2 
antibody and sera from shrimp-sensitive patients indicate that arginine 
kinase is a common allergen among crustaceans, in addition to tropomyosin. 
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Arginine kinase has also been designated as an allergen in the moth {Plodia 
interpunctella) by Binder et al. (2001). 
Mollusks have also reported to be allergenic. The mollusks 
commonly consumed are members of class Gastropoda (e.g. limpet and 
abalone), class Bivalvia (e.g. scallop, clam, mussel and oyster) and class 
Cephalopoda (cuttlefish, squid and octopus). There are a number of 
reports on allergies to mollusks including allergies to snail (de la Cuesta et 
a l , 1989)，abalone (Morikawa et al., 1990)，limpet (Carrillo et a l , 1991; 
1994), cuttlefish (Shibasaki et al., 1989), and squid (Carrillo et al., 1992). 
Leung et al. (1996) showed that sera from patients with shrimp allergies 
reacted specifically to a 38-kDa protein in a wide variety of mollusks from 
the three classes. The IgE binding reactivity of the sera to mollusk extract 
could be inhibited by preabsoprtion with recombinant shrimp tropomyosin 
Met e 1，suggesting that tropomyosin is a common allergen among 
crustaceans and mollusks. The identity of tropomyosin as the allergens in 
mollusks has subsequently been confirmed in the three groups of mollusks. 
In gastropods, Lopata et al. (1997) demonstrated the IgE reactivities 
of abalone {Haliotis midae) sensitive subjects to two major allergens with 
molecular weights of 38 kDa and 49 kDa. While the 38-kDa protein is 
believed to be tropomyosin, the identity of the 49-kDa allergen, named Hal 
m 1，remains to be identified. Ishikawa et al. (1998) purified a 35-kDa 
allergen (Tuc c 1) from the top shell Turbo cornutus. The amino acid 
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composition and partial amino acid sequences of Tur c 1 suggest that it is 
tropomyosin. Asturias et al. (2001) isolated and cloned tropomyosin from 
Helix aspersa (brown garden snail) and found that the tropomyosin (Hel as 
1) is a 36-kDa protein and shares 84% amino acid sequence identity with 
abalone {Haliotis diversicolor), 70% with mussel {Mytilus edulis) and 72% 
with scallop (Chlamys nobilius) tropomyosins. Western blot inhibition of 
different mollusk and crustacean extracts showed cross-reactivity between 
Helix aspersa, cuttlefish, octopus, sea snail and shrimp. The IgE-binding 
capacity of the recombinant Hel as 1 is weaker than its natural counterpart, 
possibly due to the absence of some conformational epitopes or improper 
folding of the recombinant protein. These studies demonstrate that 
tropomyosin is a major allergen in various gastropod mollusks. 
Among bivalves, it is well known that oyster can cause 
hypersensitive reactions upon ingestion, as well as occupational reactions in 
sensitized workers (e.g. Wada et al., 1967). Oyster and crustacean 
allergens possibly share common antigen epitopes; i.e., the common 
primitive allergenic structure shared by the two taxa is conserved in 
evolution (Lehrer and McCants, 1987). Ishikawa et al. (1997) purified two 
biochemically similar allergens (Cra g 1 and 2) from the Pacific oyster 
Crassostrea gigas by gel permeation chromatography, ion exchange FPLC 
— and reverse-phase HPLC. Their molecular weights and amino acid 
composition strongly suggest they are isoforms of tropomyosins (Ishikawa 
et al., 1997; 1998a, b). Leung and Chu (2001) suggested that Cra g 1 and 2 
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represent the same or similar isoforms of oyster tropomyosins and they 
should be designated as Cra g 1.01 and Cra g 1.02. In the same study, 
tropomyosin (Cra g 1.03) was confirmed to be the oyster allergen using 
recombinant DNA technology. Patwary et al (1999) isolated and 
characterized cDNA clones encoding tropomyosin from adductor muscle of 
sea scallop (Placopecten magellanicus). The cDNA encodes an open 
reading frame of 284 amino acids and this protein has a molecular weight of 
approximately 30 kDa. The amino acid sequence is about 70% identical to 
tropomyosins from other mollusks. Using Reverse Transcriptase-PCR, 
Chu et al. (2000) amplified tropomyosin cDNA from abalone {Haliotis 
diversicolor), scallop {Chlamys nobilis) and mussel {Perna viridis). The 
cDNAs were cloned and expressed, and the IgE reactivity of the 
recombinant proteins was demonstrated. A comparison of amino acid 
sequences of tropomyosins of the three mollusks to those of a wide variety 
of mollusks available from the GenBank database shows that they are highly 
conserved (identity >68%). 
Tropomyosins have also been identified as allergens in cephalopods. 
Miyazawa et al. (1996) isolated a 38-kD heat-stable allergen (Tod p 1) from 
the squid Todarodes pacificus by column chromatography. The peptide 
sequences of Tod p 1 exhibits significantly high homology to the snail 
tropomyosin. Ishikawa et al. (2001) identified a major allergen, Oct v 1, in 
muscle of octopus {Octopus vulgaris) by gel filtration and liquid 




amino acid sequence indicate that this allergen is tropomyosin. 
Competitive ELISA inhibition experiments suggested that there is 
cross-reactivity between Oct v 1 and Tur c 1 (top shell Turbo cormtus 
allergen). 
Food allergens are able to sensitize and elicit IgE reactions after oral 
exposure. Related food items are believed to trigger the same responses, 
leading to cross-reactivity. For example, Ayuso et al. (1999) demonstrated 
cross-reactivity between meats. IgE reactivities to beef and lamb are most 
frequent, followed by venison, pork and chicken. The possible reason of 
cross-reactivity would be the presence of shared or common epitopes on 
antigens and the conformational similarity of epitopes to which the antibody 
would bind with similar affinity. 
The cross-reactivity among crustaceans has long been documented 
(Lehrer and McCants, 1987; Halmepuro et al., 1987; Carrillo et a l , 1992; 
Witteman et al., 1994). Daul et al. (1992) demonstrated that monoclonal 
antibodies against shrimp Pen a 1 exhibit similar reactivity patterns to 
crayfish, crab and lobster antigens. Leung et al. (1996; 1998a, b) 
demonstrated that sera from shellfish allergic patients lose their IgE 
reactivities to crude crustacean extracts when they are preincubated in 
recombinant proteins Met e 1, Pan s 1 or Horn a 1. These studies represent 
the first evidence of cross-reactivity at the molecular level between different 
crustacean species that accounts for previous results on the allergic 
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cross-reactivity between crustaceans (Halmepuro et al., 1987; Lehrer and 
McCants, 1987; Carrillo et al. 1992; Witteman et al., 1994), suggesting that 
crustacean tropomyosins share common allergic epitopes. Cross-reactivity 
between crustaceans and mollusks has also widely reported (Lehrer and 
McCants, 1987; Carrillo et al. 1991; 1992; 1995). For example, Goetz & 
Whisman (2000) reported a case of a seafood handler who is sensitive to 
both shrimp and scallop. Cross-reactivity between the crustaceans and 
mollusks at the molecular level was demonstrated by Leung et al. (1996). 
Immunoblotting of sera from subjects sensitive to shrimp showed positive 
results against muscle extracts from bivalves, including mussel, fan shell, 
clam, oyster, and scallop, gastropods, including abalone, whelk, and 
cephalopods, including cuttlefish, squid, and octopus. Thus tropomyosin is 
the major cross-reactive allergen among crustaceans and mollusks. Leung et 
al. (1996) also demonstrated that IgE antibodies in sera of crustacean allergy 
subjects reacted with insects, suggesting that allergic cross-reactivity occur 
among all arthropods. Thus tropomyosin serves as a good molecular 
model for investigating the relationship of protein structure and allergenicity. 
It should also be noted that IgE against shellfish tropomyosins does not 
cross-react with vertebrate tropomyosins. 
2.4 Use of animal model in the studies of food allergy 
Animal models of allergy studies refer to the use of animals to test 
for the allergenicity of particular food items or to mimic the biochemical 
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reactions in human, thus allowing us to investigate the physiological basis of 
allergic and other biochemical reactions related to food allergy. The use of 
animal models in food allergy have been reviewed recently by a number of 
research groups (Buchanan and Frick, 2002; Helm, 2002; Helm and Burks, 
2002; Tang et al. 2003). Animal models have been widely used in the 
understanding of a variety of human diseases and developing therapeutic 
modalities (Szelenyi, 2000; Inman, 2000). Transgenic (e.g. Moser et al., 
2001) and gene knock-out animals (e.g. Xia et al., 1999) have always been 
used in scientific researches in genetics, biochemistry, immunology, 
physiology, and pharmacology. Recently, the rapid developments of 
agricultural biotechnology introduce new biological varieties and new 
proteins as food items. These new food items may contain food allergens 
after insertion of new genes. There is a problem of potential allergenicity 
of these proteins which pose a major concern in safety assessment of food. 
As these potential food items may become the major diet in human society, 
it is necessary to use animals to test for the allergenicity of food items 
before public consumption. In light of this, animal models for determining 
allergenicity of food proteins are urgently needed. 
The application of animal model in allergy began when Mota (1963) 
demonstrated that the bacterium Bordetella pertussis and its vaccine as 
adjuvant could elicit detectable IgE antibody level in sensitized rats. 
However, animal model is seldomly used in studies of food allergy until the 
late 1970s. Guinea pigs have been extensively used for the investigation of 
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infant milk formulas (Devey et al., 1976; Coombs et al., 1978; Zeiger, 1990; 
Piacentini et al., 1991; Boner et al., 1992). Atopic dogs have also been 
used in the study of milk allergy in infant because human and dog share 
many of the same allergies to food. Buchanan and Frick (2002) 
summerized recent works on wheat and milk allergy using dog as the model. 
Pups injected subcutaneously with wheat or cow's milk exhibited positive 
skin test and produced specific IgE antibodies to both foods (Buchanan et al., 
1997). When the sensitized pups were fed with wheat or cow's milk, they 
exhibited vomiting and diarrhea. Further analysis using different wheat 
proteins showed that gliadins were the strongest allergen. The skin test 
result with milk revealed that p-lactoglobulin is the major allergen, which is 
also the allergen causing milk allergy in human (del Val et al. 1999). 
The physiological and immunological similarity between pig and 
human has made the pig an important large animal model for biomedical 
research, including studies of food allergy. Helm et al. (2002) successfully 
developed a neonatal pig model of peanut allergy that mimics allergic 
symptoms and histological profile of human peanut allergy. The pigs were 
sensitized with peanut extract using cholera toxin as an adjuvant. After 
challenge, positive results were obtained from the skin test. Histological 
analysis showed mononuclear infiltration within the mucosa and mild 
hemorrhage at the superficial surface or the glands below the epithelium in 
stomach. The results indicate that the neonatal swine model is useful in 
elucidating gastrointestinal immunological responses involved in food 
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allergy. The physiology of pig closely mimics that in human, but the 
research is limited to Thl and Th2 profiles and anaphylactic antibody 
responses because of the lack of information on the pig immune system. 
The lack of commercial or known assay for determining swine IgE also 
limits the use of pig as the animal model. Other drawbacks include the 
high operating cost and the small number of animal centers with large 
animal facilities. 
The most preferred model in food allergen is the murine model. The 
murine model can be classified into two types, mouse and rat. Mice are 
commonly used in the study of food allergy. Its advantages reside 
primarily in its small size, easy handling and relative low cost of 
maintenance, and therefore, the possible use of larger sample size in 
experimental studies. Another major advantage of mouse model is that its 
immune system is well understood. Li et al. (2000) demonstrated that mice 
sensitized with peanut allergen exhibit similar pattern of allergic symptoms 
as in human patients challenged with the same allergen. In this study, 
C3H/HeJ mice were sensitized with whole peanut, using cholera toxin as 
adjuvant. IgE antibodies binding patterns in the sera of mice with peanut 
allergy were similar to those in patients with peanut allergy. The mouse 
model also helps us in elucidating the role of cytokines in the regulation of 
food allergy, van Halteren et al (1997) used ovalbumin (OVA) to sensitize 
Balb/C mice with alum as adjuvant. The ovalbumin-challenged mice 
showed elevation of IgE and histamine levels after intragastric challenge as 
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compared to control. Treating animals with antibodies against IL-4 or 
IL-10 could block the elevation in IgE and histamine levels after oral 
challenge, indicating that the two interleukins are important in IgE and 
histamine production. This study thus shows an important correlation 
between Th2 cytokines, IgE production and histamine release. A recent 
study demonstrated that epicutaneous exposure to food allergen could 
induce Th-2 predominant immune response (Hsieh et al., 2003). Balb/C 
mice were shaved on the back and OVA was applied to a patch of the shaved 
skin. Mice were then orally challenged with OVA and high level of 
OVA-specific IgE was detected. Subsequent oral challenge resulted in 
elevated plasma histamine levels and histological changes in intestine and 
lung. 
In addition to mice, rats are also a common, important model for 
food allergy studies. The advantage of using rat as the model is that it can 
easily be sensitized. Moreover, the rat immune system is well understood. 
In recent years, the brown Norway rat is the common strain used in studies 
of fool allergy. This strain was found to be a high responder of IgE without 
the use of adjuvant (Knippels et al” 1999a). Among the different strains of 
rats tested (Wistar, Pebald Virol Glaxo, Hooded Lister and brown Norway 
rats), only the brown Norway rat developed ovalbumin-specific IgE 
antibodies upon oral exposure to OVA without the use of adjuvant (Knippels 
et al” 1999b). This provides a significant breakthrough in animal model 
research of food allergy. And the sensitization method adopted by 
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Knippels et al (1998) was regarded as the standard protocol for 
sensitization in the brown Norway rat. 
2.5 Future approaches for the treatment of food allergy 
Since there is currently no effective therapy for IgE-mediated food 
allergy, a variety of different approaches have been suggested. The 
common aim is to re-establish the balance between Thl and Th2 response or 
block the antigen specific IgE reaction. Some of the methods are discussed 
below. 
The development of DNA vaccine is a novel method of generating 
immune responses by immunizing bacterial plasmid DNA encoding specific 
allergen (Masako et al., 2002). The injected DNA vaccine encoding 
specific allergen is taken up by the cells and produces endogenous protein. 
This results in presentation of allergen in MHC Class I molecules rather 
than MHC Class II molecules. This modulates the lymphocytes on the 
immunogenicity nature for the specific allergen. Raz et al. (1996) also 
showed that the immunostimulatory sequences consisting of unmethylated 
cytosine and guanine motifs in the backbone of plasmid DNA would redirect 
the allergic responses to Thl response. The effectiveness of DNA vaccine 
is still under investigation, but preliminary studies from different research 
groups demonstrate that DNA vaccine can have certain protective effect in 
animal models using oral or intramuscular administration of the vaccine (Li 
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et al., 1999; Roy et al., 1999). 
Humanized monoclonal anti-IgE antibodies which bind the Fc 
receptor of IgE molecules have recently developed. The binding of 
antibodies blocks the interaction of IgE with mast cells necessary for further 
immunological reactions. A number of clinical trials have reported that the 
use of this kind of anti-IgE monoclonal antibodies gives satisfactory results 
in treating allergic asthma and rhinitis patients (Demoly and Bousquet, 1997; 
Casale et al., 1997; Leung et al., 2003). The antibodies also downregulate 
the basophil histamine and FcsRI receptor during anti-IgE therapy 
(MacGlashan et al , 1997). 
Numerous studies demonstrate that Th2 cytokines play a central role 
in pathogenesis of allergic reactions. Th2 cytokines, including IL-4, IL-5, 
IL-10 and IL-13, promote the growth and differentiation of their subsets, 
recruit other T cells and inhibit the growth and differentiation of opposing 
subsets (Seder and Paul, 1994). The suppression of Th2 responses by Thl 
cytokines is of interest in the development of food allergy treatment. 
Wills-Karp (2001) showed that administration of cytokine IL-12 produced 
by antigen presentation cells promotes T cells to differentiate to Thl cells 
and inhibits differentiation to Th2 cells, thus suppressing IgE synthesis. 
Using animal model, Lee et al. (2001) demonstrated that oral administration 
of IL-12 was effective in reducing the allergic responses and had preventive 
effects from Th2 response. The allergen-specific IgE level was reduced 
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and IFN- y level of the animal increased. It suggests that the use of 
cytokines for treatment of food allergy is possible. 
Gut microflora is an important constituent in the intestine's mucosal 
barrier. Probiotic bacteria have been shown to have reinforcement effect in 
gut defense system (Isolauri, 1997). Degradation of food allergens with 
bacterial-derived enzymes reverses the immunogenic nature of the allergens 
from proliferation of the lymphocytes to suppression. It may be a novel 
approach for treatment of food allergy. 
Increasing understanding of Chinese medicine has a great impact of 
modern Western medicine. Recently, the potential of traditional Chinese 
medicine herbs as therapeutic treatment of food allergy has been 
investigated. Li and Sampson (2002) suggested the use of traditional 
Chinese medicine for treatment of allergic asthma. This provides the basis 
for using herbs in food allergy treatment. They suggested that the herb can 
reduce mast cell degranulation and histamine release, but it does not have 
suppressive effects on immune system or toxicity. However, there is still a 
long way to go before an effective and safe therapeutic method for food 




Cloning and expression of recombinant tropomyosin 
3.1 Introduction 
In this chapter, the objective is to produce recombinant protein of the 
shrimp tropomyosin from Metapenaeus ensis by recombinant DNA 
technology. The expressed and purified shrimp tropomyosin would be 
used to feed mice aiming to elicit immune responses for further studies on 
the effect of tropomyosin on mice (Chapter 4). The tropomyosin cDNA of 
Metapenaeus ensis was isolated by Leung et al. (1994). The clone was 
expressed in a glutathione-S transferase (GST) plasmid system for 
recombinant protein. GST has a considerably large molecular size (29 kDa) 
comparing with that of tropomyosin (34 kDa) and may alter the 
conformation of tropomyosin. Therefore in the present study, the clone was 
subcloned into the his-tag expression vector pQE30. Six consecutive 
histidine molecules were used as a tag (His-tag) which has a smaller 
molecular size and would not make a remarkable change in the 
conformation of the tropomyosin. Moreover, His-tag is also apparently 
non-allergenic and seldomly contributes immunogenicity to the animals. 
In this chapter, the cloning and expression of recombinant 
Metapenaeus ensis tropomyosin are presented. The procedures include (1) 




sequencing the DNA in the plasmid，and (4) expression, production and 
storage of the recombinant protein. 
3.2 Materials and Methods 
3.2.1 Design of PGR primers for amplification of tropomyosin gene 
The tropomyosin gene was amplified from a Metapenaeus ensis 
tropomyosin cDNA clone (Leung et al., 1994) by polymerase chain reaction 
(PCR). The sequences of the primers were designed based on the sequence 
of Metapenaeus ensis tropomyosin (GenBank accession number Q25456) 
with the addition of multiple cloning sites of the his-tag expression vector 
pQE (QIAGEN, Cat. No. 32179) at the 5，end. The forward primer (Met e 
1 一 For) locates 27 bp upstream the start codon of the tropomyosin gene. 
The reverse primer (Met e 1 - Rev) locates 30 bp downstream the stop 
codon. The expected size of the PCR product is 843 bp. The sequences 
of the primers are: 
Met e 1 - For 5, - CGCGGATCCG AATTCTGCGG CCGCCAG - 3， 
Met e 1 - Rev 5’ - CGGGGTACCG TAGCCAGACA GTTCGCTG - 3’ 
Multiple cloning sites for restriction enzyme Bam HI (GGATCC) and Kpn I 
(GGTACC) are underlined. 
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3.2.2 Cloning of PCR-amplified cDNA into vector 
Plasmids of the original clone were obtained by the plasmid 
extraction using QIAprep® Spin Miniprep kit (QIAGEN, Cat. No. 27104). 
The procedures of the extraction recommended by the manufacturer were 
followed. The plasmids were stored at -20°C before use. 
The PGR mixture for amplification of tropomyosin gene included 2 
III of plasmid DNA (50 ng/|il), 2.5 of 15 mM MgCl2 PGR buffer (lOX), 
0.5 [l\ of deoxynucleotide triphosphate mix (dNTPs, 10 mM each), 2.5 units 
of Tag polymerase (5 units/^il), 1 [i\ of each primer stock solution (12.5 [iM) 
and 17.5 [i\ ddHzO. 
The profile of PGR cycle was as follows: 
5 minutes at 94�C for initial denaturation, followed by 5 cycles of 1 minute 
at 94°C, 1 minute at 55°C, 1 minute at 72°C, then 15 cycles of 1 minute at 
94°C，1 minute at 72°C and final extension for 10 minutes at 72°C. 
The PGR product was analysed by 1% agarose gel electrophoresis. 
A bright single band in the gel with a size of around 850 bp was isolated 
from the gel. The PGR product was then purified using QIAquick gel 
purification kit (QIAGEN, Cat. No. 28740). The procedures recommended 
by the manufacturer were followed except in the last step in which sterile 




The PGR product was subsequently subcloned into the his-tag 
expression vector pQE30 using the kit provided by manufacturer (QIAGEN, 
Cat. No. 32179). This produced a N-terminally 6 x his-tagged fusion 
protein (Fig. 3.1). Gel-purified PGR products of 15 in volume were 
digested by 1 \i\ Bam HI restriction enzyme solution (Promega, Cat. No. 
R6021)，1 |xl Kpn I restriction enzyme solution (Promega, Cat. No. R6341), 
2 III multicore buffer (lOX) and 1 d d H � � f o r 3 hours at 37°C. The same 
procedures were applied to the restriction digestion of plasmid pQE30 
(QIAGEN, Cat. No. 33903). pQE30 vector of 1 i^l (500 ng/^il) was used in 
digestion. After restriction digestion, both digested PGR products and 
plasmids were purified by 1% agarose gel electrophoresis and the QIAquick 
gel purification kit as described above. Purified PGR products and 
plasmids were ligated by T4 DNA ligase (Promega, Cat. No. Ml801) 
overnight at room temperature. Ligation of plasmid pQE30 alone was 
included as control to show the effectiveness ligation enzyme. The 
procedures for ligation of plasmids and PGR products were recommended 
by the manufacturer with slight modifications as follows: 
Ligation of the plasmids and PCR products 
T4DNA ligase (1 - 3 u/^il) 1 jil 
T4 DNA ligase buffer (lOX) 1 i^l 
Digested pQE30 plasmids 2 \i\ 
Digested PCR products 4 
ddHsO 2 III 
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The ligated products were stored at -20°C until use. 
3.2.3 Transformation of competent E. coli Ml 5 cells 
Frozen E. coli Ml5 of 100 competent cells (from QIAexpress 
Type IV kit, Cat. No. 32149) was thawed on ice. The bacteria were then 
resuspended and transferred into a tube containing 10 |il of ligation mixture. 
The tube was incubated in ice for 20 minutes and subsequently in a 42°C 
water bath for 90 seconds. Psi broth (500 |il) was added into the cells and 
incubated at 37°C for 90 minutes with shaking. The bacterial culture was 
plated on the LB-agar containing 25 ^ig/ml kanamycin and 100 |ig/ml 
ampicillin at 37°C overnight. 
3.2.4 Confirmation of DNA sequence of the cloned vector 
Single colony from the bacterial plate was picked for sequencing to 
confirm the presence of the cDNA insert in the colony. Briefly, a single 
colony of bacteria was placed in PGR reaction buffer. PGR procedures 
were described above. After the correct colony was selected, plasmids of 
the bacteria were collected by the QIAprep® Spin Miniprep kit (QIAGEN, 
Cat. No. 27104) for DNA sequencing. 
Purified plasmids (4 |il) were sequenced using Dye Terminator Cycle 
Sequencing Ready Reaction Kit (Applied Biosystems, Part No. 4020790) 
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and analysed on an ABI 310 Genetic Analyser (Applied Biosystems). The 
sequencing procedures recommended by the manufacturer were modified as 
follows: 
Cycle sequencing 
Sequencing reaction mix was prepared as follows: 
Terminator Ready Reaction mix 8.0 i^l 
Template (Plasmid) 4.0 fil 
Primer (one of the primers used in PCR) 3.2 pmole 
Add deionized H2O to final volume 20 i^l 
The cycling profile was as follows: 
1 minute at 96°C for initial denaturation, 25 cycles of 10 seconds at 96°C, 5 
seconds at 50°C, and 4 minutes at 60°C, and then kept at 4°C. 
3.2.5 Expression of recombinant protein 
The colony with confirmed DNA sequence was selected for the 
expression of recombinant protein. The cells were streaked onto LB plates 
containing 25 昭/ml kanamycin and 100 fig/ml ampicillin and incubated 
overnight at 37°C. The colonies on the plates were maintained at 4°C for a 
week in preparation of frozen bacterial stock. Bacterial culture (1.5 ml) 
was centrifuged at 10,000 rpm for 1 minute. After supernatant was 
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discarded, 1 ml of LB broth without antibiotics was added to resuspend the 
cell pellets. The solution was centrifuged at 10,000 rpm for 1 minute. 
Supernatant was removed leaving the last 200 |il. Cells were mixed with 
800 |il LB broth with glycerol. The bacteria were immediately grown for 
experiment or stored at -70°C until use. 
For the growth of bacteria, they were inoculated in 10 ml LB broth 
containing 25 [ig/ml kanamycin and 100 |ig/ml ampicillin at 37°C overnight 
with shaking. The overnight culture was then incubated in 500 ml LB 
broth containing 25 [ig/ml kanamycin and 100 |ig/ml ampicillin at 37°C 
with shaking until an ODeoo of 0.6 was reached. IPTG was then added to 
the bacterial culture for induction of recombinant protein overnight at a final 
concentration of 1 mM. The cells were harvested by centrifugation at 
10,000 rpm for 30 minutes. Cell pellet was stored at -20°C until use. 
3.2.6 Purification of recombinant protein under native condition 
The procedures were modified from the instructions provided by the 
‘ manufacturer (QIAGEN, Cat. No. 32179). The frozen cell pellet was 
thawed for 15 minutes on ice and resuspended by cell lysis buffer (6.90 g 
NaH2P04 .H2O, 17.54 g NaCl, 0.68 g imidazole, pH 8.0 in 1 1 ddHzO) with 
2-5 ml cell lysis buffer per gram of cell pellet. Lysozyme (1 mg/ml) was 
added to the supernatant and the mixture was incubated on ice for 30 
minutes with stirring. The supernatant was sonicated on ice for 60 seconds 
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at 200 W at 10-sec intervals. The cell lysate was then centrifuged at 
10,000 rpm for 25 minutes at 4°C. The supernatant was saved for further 
purification. 
50% Ni-NTA slurry provided by the manufacturer was added to the 
cell lysate (Ni-NTA: cell lysate = 1 : 4 ) and mixed gently by shaking at 4°C 
for 1 hour. The mixture was added into the column with the bottom outlet 
capped. The cap was then removed and the solution was allowed to elute 
from the column. The column was washed with 4 ml wash buffer (6.90 g 
NaH2P04.H20, 17.54 g NaCl, 1.36 g imidazole, pH 8.0 in 1 1 ddH20) twice. 
The wash buffer eluted from the column was collected for analysis. 
Elution buffer of 0.5 ml (6.90 g NaHaPO+HaO，17.54 g NaCl, 17.0 g 
imidazole, pH 8.0 in 1 L ddHzO) was then added into the column and 
subsequently collected. The column was further eluted with 0.5 ml elution 
buffer for 5-10 times. 
3.2.7 Concentration measurement and storage of recombinant protein 
The solution collected from the column was then placed in a dialysis 
tubing with 10 kDa molecular weight cutoff. The tubing was placed in a 
beaker with 3 1 PBS and stirred overnight at 4°C. The solution in the 
dialysis tubing was then collected and the protein concentration of the 
solution was measured. Bovin serine albumin (BSA) provided by the 
manufacturer (PIERCE, Cat. No, 23235) was used as a reference protein in 
I ) 
37 
determining the concentration of tropomyosin in the solution by comparing 
their absorbance. Briefly, the BSA was diluted by PBS to the highest 
concentration of 2 mg/ml. The protein ladder was then diluted by two-fold 
dilution with PBS to the lowest of 0.03125 mg/ml. The working buffer 
provided by the manufacturer was added to both the samples and the 
standard (working buffer : sample = 1 : 1 ) . PBS was used as the control. 
They were incubated at 37°C for 30 minutes. OD561 was measured and the 
concentration of the protein was estimated using BSA standard curve. The 
remaining solution was stored at -70°C until they were frozen. The frozen 
material was then lyophilized at vacuum and -200°C to allow the lysate to 
dry up into solid form. They were stored at -20°C until use. 
3.2.8 Sodium dodecyl sulfate polyacrylamide gel eletrophoresis 
(SDS-PAGE) 
Samples from IPTG-induced bacteria, cell lysate after centrifugation, 
eluent from column after washing, the eluent from the column after addition 
of elution buffer and the purified protein from the dialysis tubing were 
analysed by SDS-PAGE. Each protein sample of 10 |il (approximate to 10 
i^g) was mixed with 10 [d 2X sample buffer (3.0 g Tris, 14.8 g EDTA, 4 g 
SDS, 10 ml 2-inercaptoethanol, 20 ml glycerol, 40 mg bromophenol blue, 
— pH 6.8 in 100 ml ddHiO) and heated at 95°C for 5 minutes. The denatured 
protein samples were analyzed by SDS-PAGE on 4% stacking gel (1.25 ml 
0.5 M Tris at pH 6.8, 2.85 ml ddE^O，50 |il 10 % SDS, 37.5 10% 
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ammonium persulfate, 5 [d TEMED [N，N，N’， N , -
tetramethylethylenediamine], and 0.85 ml 40% acrylamide/bis solution 19:1) 
and 12.5% separating gel (2.5 ml 1.5 M Tris at pH 8.8，4.0 ml ddHiO, 100 
10% SDS, 4.25 ml 40% acrylamide/bis solution 19:1, 75 10% 
ammonium persulfate, and 10 |xl TEMED). 
The gel was run at constant voltage of 120 volts in IX SDS-PAGE 
electrode running buffer prepared from lOX SDS-PAGE electrode running 
buffer (30.3 g Tris, 10 g SDS, and 137.3 g glycine in 1 1 ddHbO). 
Electrophoresis was terminated when the tracking dye bromophenol blue 
just disappeared from the bottom of the gel (about 90 minutes). The 
molecular weight markers (Bio-Rad, low range SDS-PAGE standard, Cat. 
No. 161-0304) were run together with the samples. 
The gel was then stained with staining solution (2.5 g brilliant blue R, 
70 ml acetic acid, and 400 ml methanol in 1 1 ddHzO) for 20 minutes with 
shaking. It was then destained subsequently with two destain solutions 
(250 ml methanol, 50 ml acetic acid in 200 ml d d H � � a n d 25 ml methanol, 
35 ml acetic acid in 440 ml ddEbO) each for 20 minutes with shaking. The 
gel was then cleaned by 10% acetic acid overnight with shaking. The gel 
was photographed, dried and wrapped. 
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3.2.9 Regeneration of the Ni-NTA column 
After the Ni-NTA slurry was used in purification for over 10 times, 
the affinity of Ni-NTA slurry to recombinant protein decreased. It was 
necessary to regenerate the Ni-NTA slurry before further purification of 
recombinant protein. 
The Ni-NTA slurry was regenerated by washing with the following media in 
sequence: 
(1)2 volume regeneration buffer (6 M GuHCl, and 0.2 M acetic acid); (2) 5 
volume of H2O; (3) 3 volume of 2% SDS; (4) 1 volume 25% alcohol; (5) 1 
volume 50% alcohol; (6) 1 volume 75% alcohol; (7) 5 volume 100% alcohol; 
(8) 1 volume 75% alcohol; (9) 1 volume 50% alcohol; (10) 1 volume 25% 
alcohol; (11) 1 volume H2O; (12) 5 volume lOOmM EDTANiS04,pH 8.0; 
(13) 1 volume H2O; (14) recharge 2 volume 100 mM NiS04； (15) 2 volume 







T5P/lacO — ATG — 6xHis — Mete 1 — Stop 
I PQE-30 vector 
Figure 3.1 pQE 30 vector for production of recombinant tropomyosin. 
The vector contained a Col El origin of replication (Col El), an ampicillin 
resistance gene (Ampicillin), a T5 promoter (T5P), two lac operators (lac O), 




3.3 Results and discussion 
3.3.1 DNA sequence of the cloned vector 
After the bacteria E. coli M 15 were transformed, PGR reaction was 
the quickest method to confirm the presence of PCR products in the plasmid 
pQE30. Gel electrophoresis of PCR products showed a single band with 
size around 850 bp (Fig. 3.2). This single band corresponded to the 
tropomyosin gene inserted into the plasmid. This band was isolated, 
purified，and sequenced. DNA sequencing results of the PCR products 
confirmed that the single band corresponded to shrimp {Metapenaeus ensis) 
tropomyosin DNA (Fig. 3.3). The sequence of the PCR products is 
identical to that in original clone of shrimp tropomyosin isolated by Leung 
et al. (1994) (GenBank Accession number Q25456). 
3.3.2 Sodium dodecyl sulfate polyacrylamide gel eletrophoresis 
(SDS-PAGE) 
SDS-PAGE of protein samples collected during purification process 
showed a sharp single band around 34 kDa (Fig. 3.4). This band 
corresponded to recombinant tropomyosin induced in the experiment. This 
single sharp band first appeared in the ITPG-induced bacteria, and also cell 
supernatant after centrifugation process. Since it bound strongly in the 
column, no recombinant protein was collected after the addition of wash 
buffer to remove the impurities in the column. The recombinant protein 
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was eluted out from the column after the addition of elution buffer. The 
recombinant protein purified by dialysis contained no impurity as shown by 
SDS-PAGE analysis. This single band has a molecular weight of 34 kDa 
which is consistent with the result of Leung et al. (1994). 
3.3.3 Expression of the recombinant protein 
The yield of recombinant protein produced was 1.2 mg/ml after 
purification by dialysis. One liter LB broth could generate approximately 
2 to 5 mg recombinant protein. A His-tag fusion protein of the shrimp 
tropomyosin was successfully expressed in E. coil Ml5. This 34 kDa 
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600 bp I^ HIIHI Figure 3.2 Agarose gel showing the PGR products of tropomyosin gene amplified using designed primers. Lanes 1-5: PGR products; Marker 1:mass la der (Invitro n, Cat. No. 10496-0 6); Marker 2: 100 bp ladder(Invitrogen, Cat. No. 15628-019). I » 4 4 
1 GAATTCTGCG GCCGCCAGGC GATGAAGCTG GAGAAGGATA ACGCCATGGA CAGGGCGGAT 
61 ACCCTTGAAC AGCAGAACAA GGAGGCCAAC AACAGGGCTG AGAAGAGCGA GGAGGAGGTT 
1 2 1 CACAATCTTC AGAAGAGGAT GCAGCAGCTT GAGAACGACC TTGATCAGGT GCAGGAATCC 
1 8 1 TTGCTGAAGG CAAACAACCA GCTCGTGGAG AAGGACAAGG CCCTCTCTAA CGCTGAGGGT 
2 4 1 GAGGTTGCTG CTCTTAACCG CCGCATCCAG CTGCTCGAGG AGGACCTGGA GCGCTCTGAG 
3 0 1 GAACGCCTCA ACACCGCCAC CACCAAGCTG GCTGAGGCCT CCCAGGCCGC CGACGAGTCC 
3 6 1 GAGCGCATGC GCAAGGTGCT CGAGAACCGC TCCCTTTCCG ATGAGGAGCG CATGGACGCC 
4 2 1 CTGGAGAACC AGCTCAAGGA GGCCCGCTTC CTGGCTGAGG AAGCCGACAG GAAATACGAC 
4 8 1 GAGGTTGCCC GTAAGCTGGC CATGGTTGAG GCCGACCTTG AGCATGGTTG AGAACGTGCT 
5 4 1 GAGACTGGTG AATCAAAGAT CGTCGAGCTT GAGGAAGAAC TGCGTGTCGT TGGCAACAAC 
6 0 1 CTGAAGTCTC TTGAGGTTTC CGAGGAGAAG GCTAACCAAC GCGAAGAGGC CTACAAGGAG 
6 6 1 CAGATCAAGA CCCTGACCAA CAAGCTGAAG GCGGCTGAGG CTCGCGCTGA GTTCGCCGAG 
7 2 1 AGGTCTGTGC AGAAACTCCA GAAGGAGGTC GACAGGCTCG AAGACGAACT GGTTAACGAA 
7 8 1 AAGGAGAAGT ACAAGTCCAT TACCGACGAG CTGGACCAGA CTTTCGACGA ACTGTCTGGC 
8 4 1 TACACCCCGG GTCGACCTGC AGCCAAGCTT AATTAGCTGAG 
Figure 3.3 Nucleotide sequence of the cloned Met e 1 in pQE30. Note 
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Figure 3.4 SDS-PAGE of recombinant protein obtained after induction 
and purification. Lane 1: Bacterial cells after IPTG induction; Lane 2: Cell 
supernatant after sonication and centrifugation; Lane 3: Eluent collected 
after first washing; Lane 4: Eluent collected after second washing; Lane 5: 
Eluent collected after addition of elution buffer; Lane 6: Recombinant 
protein obtained after dialysis; Marker: low range protein ladder (Bio-Rad, 





Induction of shrimp tropomyosin-specific IgE response in mice 
4.1 Introduction 
At present, there is no effective therapeutic strategy in curing food 
allergy. In 1960s, sodium cromoglycate was shown to be effective in 
treatment of asthma and allergic rhinitis and conjunctivitis, but oral 
administration of sodium cromoglycate has remained controversial in 
reducing adverse reactions to food (Basomba et al., 1977; Vaz et a l , 1978). 
Both Harries et al. (1978) and Edwards (1995) reported that treatment of 10 
patients with either an urticarial response or an asthmatic response to food 
challenge showed no protective effect using sodium cromoglycate. Thus 
the need of a reliable and effective therapeutic strategy in food allergy is 
highly warranted. 
A number of studies on food allergens implicated that food allergens 
are highly stable to digestive enzymes and that the stability to digestion is a 
significant criterion for allergenicity. It is believed that food allergens 
share some physicochemical properties which distinguish them from 
non-allergenic proteins. Using simulated gasteric fluids, Astwood and 
Fuchs (1997) showed that food allergen is stable to digestion while other 




that all food allergens have some characteristics in order to be a "good and 
effective" allergen. The allergen should be able to sensitize animal to 
produce high IgE antibody, trigger allergic symptoms easily, soluble and 
able to cross the mucosal barrier, stable to heat and resistant to enzymatic 
digestion, and able to expose to antigen presenting cells. 
These characteristics are nevertheless a much simplified picture. 
Enomoto et al. (1993) pointed out that early research groups investigated the 
immunogenicity or induction and suppression of IgG antibodies rather than 
IgE antibody responses or allergenicity in mucosal immune responses to 
ingested proteins. The International Life Science Institute (ILSI) Allergy 
and Immunology Institute and the International Food Biotechnology 
Council recommended that the antigenic protein should be identified by 
serological methods using IgE antibody as indicator (Metcalfe et al., 1996). 
Recently, the development of animal models permits the direct evaluation of 
sensitizing potential of proteins. Measurement of induced antibody 
responses and particularly the ability of test proteins in stimulating the 
production of IgE becomes the major indicator of sensitization. Different 
investigators have selected various animal species such as mice, guinea pigs, 
rats, dogs, and pigs as experimental subjects in food allergy research 
(Ermel et al., 1997; Terpend et al., 1999; Knippels et al., 1999; Helm et al. 
2002). Among these animals, rodents are the common type of animals 
used. For instance, Balb/C mice were reported to be a good responder to 
allergen after sensitization (Dearman et al., 2001; Untersmayr et al. 2003). 
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Balb/C mice was chosen in the present study because previous work has 
demonstrated that Balb/C mice generate considerable level IgE antibody. 
Dearman et al. (2001) demonstrated that Balb/C mice elicited high IgE 
antibodies towards all the allergens tested including peanut agglutinin, OVA 
and crude potato extract. In contrast, none of the mice developed IgE 
when the mice were fed with a common foodstuff which has low 
allergenicity. This indicated that IgE response can be easily induced in 
Balb/C mice and it is an appropriate strain for the food allergy study. Not 
only the strains of mice are important factor that influence the immune 
response of mice, the age of mice is also important criteria which should 
take into an account. 
In addition to the strain and age of animals used, the extent of 
immune responses in the gut also depends on age of animals, dose and 
frequency of antigen administration and use of adjuvant to induce mucosal 
immune reactions in animal experiements (Dahlgren et al., 1991). It is 
believed that the younger the age, the better the sensitization of mice. 
Various studies (Kweon et al., 2000; Li et al., 2000; 2003; Dearman et al., 
2001; Hsieh et al. 2003) employed mice with age range from three to five 
weeks old. It is believed that immune systems of immature mice can be 
easy altered to hypersensitivity response to food allergens. Three weeks 
old female Balb/C mice were therefore used in this study. Sensitization 
methods also vary among different studies. Intraperitoneal (i.p.) (Helm et 
a l , 2002), subcutaenous (s.c.) (Li et al., 2003), intragastrical (Li et al., 2000), 
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and epicutaneous (e.c.) (Hsieh et al., 2003) methods have been used in 
animal studies. Different sensitization pathways result in different degrees 
of sensitization and IgE antibody production. It is believed that intragastric 
gavage is a better sensitization method in food allergy study as it closely 
mimics the human ingestion situation. Therefore, intragastric gavage was 
used in this study. 
The length of sensitization varied in different studies. Some 
experimental protocols adopted a longer time of sensitization [e.g. Li et al. 
(2000) sensitized animals for 14 weeks], but some used a shorter time of 
sensitization [e.g. Li et al. (1999) sensitized animals in 5 weeks]. The 
length of sensitization depends on the purpose of the experiments. With 
regard to the dosage of allergens，it is believed that a low dose of allergens is 
better than a high dose of allergens. A high dose of allergens may result in 
oral tolerance (Strobel and Mowat, 1998; Spahn et al., 2001). Timing of 
challenge is also important for IgE production. Challenge at different time 
points may affect the IgE level induced in the body. Byars and Ferraresi 
(1976) investigated the permeability of the gastrointestinal tract of rat 
towards food allergen at different challenge times by using radioactive 
bovine serum albumin (BSA) for sensitization. Mice challenged orally 
within two weeks after sensitization showed consistency in allergenic 
reactions, while mice challenged two weeks post-immunization resulted in 
lower consistency. Therefore, there is a time limit for IgE antibodies to 
reach a suitable level to induce the allergenic reactions. 
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It is believed that adjuvants can increase the permeability of intestine 
and hence promote the uptake of allergens by gastrointestinal tract to 
produce antigen-specific immune responses (McKenzie et al. 1984; 
Holmgren et al., 1993). Hence, adjuvants are often employed to increase 
the degree of sensitization. Previously, bacteria or toxins were commonly 
used as adjuvant, e.g. the bacterium Bordetella pertussis (Mota, 1963). It 
is believed that the bacterial toxin produced can increase the permeability of 
the intestine for the uptake of food substances. With more research works 
on the choice of adjuvant, bacteria or their toxins were replaced by another 
adjuvant, alum. Recently, there is a trend of change in the use of adjuvant 
from alum to cholera toxin in food allergy studies as cholera toxin was 
demonstrated to promote Th2 immune response (Rask et al., 2000). 
Therefore, in this study, cholera toxin was used as the adjuvant to promote 
the development of Th2 allergic responses. Previous studies revealed that 
the magnitude and duration of IgE antibodies production are influenced by 
the dose of antigen and timing of adjuvant administration (Nicklin et al., 
1985; Wilson et al., 1989). Some adjuvants, for instance carrageenan and 
cholera toxin, can selectively promote Th2-type cell activation and IgE 
antibodies. At the other hand, m vitro studies by Nicklin et al. (1985) on 
the effects of Gypsophila sp. saponin on mammalian small intestine 
permeability indicated that it increases the permeability of small intestine 
mucosal cells but inhibits active transport and facilitates uptake of materials 
to which gut would not normally be permeable. 
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In this study, Balb/C mice were fed with recombinant shrimp 
tropomyosin (see Chapter 3) with the aim to elicit allergic response to 
shrimp tropomyosin. The behavioral changes of mice before and after 
challenged were observed. After challenge, sera were collected for 
determination of tropomyosin-specific IgE level. Cellular proliferation 
levels of splenocytes towards tropomyosin were measured. Cytokine 
profile of splenocytes and passive cutaneous anaphylaxis (PCA) reactions of 
mice were determined. Histological changes of intestines in different 
groups of mice were also determined to assess the efficiency of 
sensitization. 
4.2 Materials and methods 
4.2.1 Mice and reagents 
Three weeks old female Balb/C mice were acquired from the 
Laboratory Animal Services Centre, The Chinese University of Hong Kong 
for experiments. Due to the fact that the mice in the Centre were infected 
by minute virus of mouse (MVM), the supply of Balb/C mice was 
temporarily suspended. Therefore, subsequent experiments were 
conducted at School of Medicine, National Taiwan University Hospital, 
National Taiwan University. In both cases, mice were maintained on shrimp 
free chow under specific pathogen-free conditions. Standard guidelines for 
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animal care and use of animals were followed. The animal experiments 
were conducted with the approval of review board in the two universities 
and the Department of Health, Government of Hong Kong Special 
Administrative Region. 
4.2.2 Animal sensitization and challenge 
Six groups of mice were included in the experimental protocol with 
5 to 14 mice in each group (Table 4.1). In three experimental groups, mice 
were fed with 0.1 mg tropomyosin with adjuvant, 1 mg tropomyosin with 
adjuvant or 0.1 mg tropomyosin alone (NT) in total volume of 1 ml. The 
adjuvant cholera toxin was used at a concentration 10 |ig per mouse. In 
control groups, mice were fed with PBS, 0.1 mg His-tag (New England 
Peptide), or 1 mg lysozyme (Sigma Cat. No. L-7651) in total volume of 1 ml. 
Cholera toxin (10 |a,g per mouse) was also used as adjuvant in these control 
groups. All materials used to feed the mice were dissolved in 1 ml PBS 
solution. PBS was used as a control group because it was a solvent in the 
experiment. Since the recombinant tropomyosin was expressed with the 
link of 6 consecutive histidine molecules as tag, His-tag was included as a 
control to eliminate the effect of histidine molecules produced in the mice. 
Lysozyme was also included in control for non-specific protein. 
In preliminary studies, mice were fed with 0.05 mg, 0.1 mg, 0.5 mg or 
2 mg tropomyosin. Serum IgE levels of those mice were determined. 
I > 
53 
ELISA results indicated that mice fed with 0.05 mg or 2 mg tropomyosin 
developed very low IgE level. Therefore 0.01 and 0.1 mg tropomyosin 
were used in subsequent experiments. 
The experimental protocol is summarized in Fig. 4.2. All mice 
were sensitized by intragastic gavage regularly in one-week interval for 
three weeks. Intragastric feeding was performed by means of a stainless 
steel blunt feeding needle. At the fourth week, mice were fasted overnight 
and challenged intragastically with a higher dose of tropomyosin. Mice 
fed with 0.1 mg tropomyosin or 1 mg tropomyosin were challenged with 1 
mg or 5 mg tropomyosin, respectively. Mice in control groups were 
challenged with 1 mg tropomyosin. 
4.2.3 Morphological and behavioral changes after challenge 
Close observation was made at the snout of the mice before sensitization 
and after challenge. The presence of any anaphylactic symptoms of mice 
including scratching and rubbing around the nose and head, puffiness 
around the eyes and mouth, diarrhea, pilar erecti, reduced activity with 
increased respiratory rate, wheezing, labored respiration, cyanosis around 
the mouth and the tail, no activity after prodding or tremor and convulsion, 




4.2.4 Tropomyosin-specific IgE level 
About 150 |il blood was drawn from the retro-orbital plexus of mice 
at weeks 1，3 (after feeding), 4 (after challenge) and 5 (Fig. 4.1). Sera were 
obtained by 1 hour of clotting at room temperature followed by 15 minutes 
of centrifugation at 5000 rpm in 4°C. Sera collected were stored in -80°C 
before analysis. Tropomyosin-specific IgE level in sera were detected by 
ELISA. Recombinant tropomyosin of 10 |ag/ml in coating buffer (0.05 M 
NaiCOs, 0.13 M NaHCOa, 0.0031 M NaNs, pH 9.6) was coated in 96 wells 
immuno plates (NUNC tm Brand Products) for 16 hours at 4 � C . The plates 
were then washed with PBS solution twice and then blocked with 3.0% 
bovine serum albumin (BSA) (Sigma Cat. No. A-6003) in PBS for 2 hours 
at 25°C. The plates were washed again in PBS Tween (0.05% Tween 20 in 
PBS solution) (BIO-RAD Cat. No. 170-6531) twice. Sera of mice were 
subsequently diluted at 1:10 with 3.0% BSA and incubated for 16 hours at 
4°C. The plates were then washed 4 times with PBS Tween and incubated 
with biotinylated anit-mouse anti-IgE antibody at 1 |ig/ml (PharMingen Co., 
Cat. No. 02132D) in 3.0% BSA in PBS for 45 minutes at 25°C. The plates 
were kept in darkness with aluminum foil for protection. The plates were 
then washed 8 times with PBS Tween. Avidin-peroxidase of 100 |il at 
concentration of 1 |ig/ml was added into each well and incubated for 30 
minutes in darkness using aluminum foil at 25°C. After 30 minutes, 
2,2-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) (Sigma Cat. 
No. A-1888) solution (0.05% ABTS, 0.03% H2O2, 0.24 M citric acid 
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monohydrate, 0.05 M Na2HP04, pH 4.2) was added as substrate. The color 
intensity developed was read using microplate reader at 420 nm. All 
assays were performed at least twice. 
4.2.5 Passive cutaneous anaphylaxis (PCA) reaction 
The procedures described by Ovary (1990) were followed with 
modifications. Sera from three to five mice in each group after challenge 
were pooled to a total volume of 50 |il. A naive Balb/C mouse of five 
weeks old was anesthetized by i.p. injection with 10% ketamine and 10% 
xylazine in sterile PBS. The back of the mouse was sprayed with 70% 
alcohol before shaving. Hair at the back was removed by hair shaver and 
sterile 1-ml 30G needles were prepared for injection. Saline or diluted sera 
(sera:saline = 1:5) was injected intradermally at the back. Normal saline 
was injected as negative control. The experiment was duplicated. Two 
hours later, the two mice were injected intravenously using 250 |a.l 0.5% 
Evan's blue dye in saline mixed with 250 jig recombinant tropomyosin. 
Thirty minutes after dye-antigen administration, wheal reactions were 
assessed. A positive reaction was regarded as a bluing of the skin at the 
injection sites that was greater than 3 mm in diameter in any direction. 
4.2.6 Tropomyosin-specific cellular proliferation level of splenocytes 
After blood collection at week five, mice were scarified by 
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dislocating the spine from brain at the neck. Spleens were removed from 
mice with sterile surgical scissors and blades. The isolated spleens were 
immediately put into the Hanks' Balanced Salt solution (HBSS) (Sigma Cat. 
No. H-2387) and kept in ice. Splenocytes were isolated from spleen 
immediately by mincing with syringe in 5 ml HBSS. The mixture was 
allowed to stand in ice for 5 minutes. Supernatant was obtained and 
centrifuged at 1500 rpm for 10 minutes at 4°C. Cell pellet was collected 
and incubated with 1 ml lysis buffer (0.15 M NH4CI, 1 mM KHCO3, 0.1 
mM Na2-EDTA, pH 7.2, 0.22 jim filtered) for 1 minute to lyse the red blood 
cells in the culture. Then, 9 ml HBSS was added to resuspend the cells for 
washing procedure. The cells were centrifuged at 1500 rpm for 10 minutes 
at 4°C. Supernatant was discarded and the cell pellet was washed by 
resuspending the pellet in 10 ml HBSS followed by centrifugation at 1500 
rpm for 7 minutes at 4°C. This procedure for washing of cells was 
repeated twice. The number of cell in the medium was counted and the 
viability of the cells was measured using hemocytometer. Cell medium of 
5 |xl was mixed with 35 of tryphan blue solution. The mixture was 
added into hemocytometer for counting the number of viable cells. The 
cells were finally incubated in complete cell culture medium (RPMI-1640 
plus 10% fetal calf serum, 1% penicillin/ streptomycin and 1% glutamine). 
For each mouse, 3 x 10^  splenoctyes per well were incubated in 96 
microwell plates in the presence or absence of tropomyosin (20 |il/ml). 
The cell culture was triplicated. Cells stimulated with 5 |xl/ml 
phytohemagglutinin (PHA) were used as positive control. The 
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non-specific protein ovalbumin (OVA) was used as negative control. 
Plates were incubated at 37°C, 5% CO2 for 48 hours. Cultures were then 
pulsed for 15 hours with 1 jxCi tritiated thymidine per well. The cells were 
harvested and incorporated radioactivity was counted in a ^  -scintillation 
counter. The results were expressed as stimulation index by dividing the 
counts per minute (cpm) with the antigen from the cpm without the antigen. 
A stimulation index greater than 3 was regarded as significant proliferation 
of splenocytes. 
4.2.7 Cytokine profiles of splenoctyes 
Splenoctyes obtained as described above were suspended in the 
complete cell culture medium (RPMI-1640 plus 10% fetal calf serum, 1% 
penicillin/ streptomycin and 1% glutamine). 1 x 10^ splenocytes per well 
were cultured in 24-well plates in the presence or absence of recombinant 
tropomyosin (20 |il/ml). Supematants were collected after 72 hours of 
incubation at 37°C and 5% CO2. Cytokines IL-4, IL-5, IL-10 and IFN-y 
were measured using ELISA kit according the manufacturer's instructions 
(Duoset ELISA kit, Cat. No. DY 404 [IL-4], DY 405 pL-5], DY417 [IL-10], 
DY 485 [IFN-y]). Briefly, the detection antibody provided by the 
manufacturer was diluted in PBS and coated onto the 96 wells immuno 
plates overnight. Plates were washed 3 times with PBS Tween followed by 
blocking with 1% BSA and 5% sucrose in PBS. Supematants of 100 |j,l 
obtained from the cell culture were added and incubated overnight at 4°C. 
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The plates were then washed 3 times with PBS Tween and 100 |il detection 
antibody in 1% BSA was added. The plates were washed 3 times with PBS 
Tween and incubated with 100 \i\ streptavidin-HRP for 20 minutes in 
darkness. Substrate solution provided by the manufacturer was added to 
the plates and color changed in the wells was read using microplate reader. 
Analysis on each mouse was performed in duplicate for high degree of 
precision. 
4.2.8 Histological examination of small intestines 
The procedures described by Li et al. (1999) and Hsieh et al. (2002) 
were followed with modifications. Infiltration of lymphocytes was 
assessed by the examination of small intestine samples of mice scarified 
after the experiment. Segments of jejunium were fixed in 10% 
neutral-buffered formalin and embedded with paraffin. Sections of tissues 
(5 |im) were cut and stained with toluidine blue or Giemsa stain for 16-18 
hours. Infiltration of the lymphocytes was observed under the microscope 
(X 400 magnification) a n d t h e presence o f lymphocytes was d e f i n e d a s the 
cells positively stained by toluidine blue or Giemsa dye with distinctly 
stained granules. 
4.2.9 Statistical analysis 
Data were analyzed using SigmaStat statistical software (SPSS). 
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For IgE and cytokine levels, the data was analyzed by 1-way ANOVA 
followed by turkey test for all pairwise comparisons. P values < 0.05 were 
considered as significant. 
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Table 4.1 Groups of mice in experiments. 
Groups Antigen Cholera toxin Number 
(10 |ig per mouse) 
Tropomyosin 0.1 mg 0.1 mg His-Tpm yes 14 
treatment groups 1 mg 1 mg His-Tpm yes 14 
NT 0.1 mg His-Tpm no 9 
Control groups PBS PBS yes 10 
His 0.1 mg His-Tag yes 10 
Lysozyme 1 mg lysozyme yes 5 
PBS: phosphate buffer saline, His-tag: six consecutive histidine, His-Tpm: 
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Fig 4.1 Experimental protocol. Balb/C mice were sensitized orally with 
recombinant tropomyosin at weekly interval. The mice at different groups were 
sensitized at the first three weeks with different treatments as shown in Table 4.1. 
Mice were challenged at week four using tropomyosin. 




4.3.1 Morphological and behavioral changes after challenge 
Mice fed with 0.1 mg tropomyosin with adjuvant, 1 mg tropomyosin 
with adjuvant and 0.1 mg tropomyosin without adjuvant (NT) swelled at the 
snout after challenge (Fig. 4.2). Rubbing around the snout, and scratching 
the whole body including the tail were observed in these groups of mice after 
3 weeks of sensitization. No other anaphylactic symptoms were observed. 
There were no swelling of the snout in groups of mice fed with PBS, His-tag 
or lysozyme. Occasional scratching behavior was observed in mice fed with 
PBS, His-tag or lysozyme. The frequency of scratching in mice fed with 0.1 
mg or 1 mg tropomyosin was higher than that in three groups (PBS, His-tag 
and lysozyme). 
4.3.2 Tropomyosin-specific IgE level 
Elevations in tropomyosin-specific IgE level were observed in mice 
fed with 0.1 mg tropomyosin with adjuvant and 1 mg tropomyosin with 
adjuvant after challenge at week 4 as well as week 5 (Fig. 4.3). Statistical 
analysis shows that IgE level in mice fed with 0.1 mg tropomyosin with 
adjuvant is significantly higher than that in PBS control at both week 4 and 5. 
Although the IgE level in mice fed with 1 mg tropomyosin with adjuvant is 




There is no significant difference in IgE level between the PBS control and 
any of the other groups including his-tag, lysozyme, and 0.1 mg tropomyosin 
without adjuvant (NT). Generally, the data on tropomyosin-specific IgE 
level showed that mice fed with tropomyosin developed 
tropomyosin-specific IgE after challenge. 
4.3.3 Passive cutaneous anaphylaxis (PCA) 
In both naive Balb/C mice, blue spots were observed at the skin 
in the area injected with sera from mice fed with lysozyme, His, 0.1 mg 
tropomyosin with adjuvant and 1 mg tropomyosin with adjuvant (Fig. 4.4). 
Among these blue spots, spots greater than three mm in diameter were 
observed only with sera from mice fed with 0.1 mg and 1 mg tropomyosin. 
Comparing these two spots, it was found that sera from mice fed with 0.1 
mg tropomyosin produced a larger area of blue color and with greater color 
intensity than those from mice fed with 1 mg tropomyosin. Injection of 




Figure 4.2 Mouse experienced hypersensitive reaction to shrimp 
tropomyosin after challenge. A: a normal Balb/C mouse before experiment. 
B: Tropomyosin-sensitized Balb/C mouse experiencing hypersensitive 
anaphylaxis reactions after intragastric feeding of tropomyosin as 
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Figure 4.3 Tropomyosin-specific IgE levels in groups of mice fed 
with phosphate buffered saline, lyzozyme, his-tag, 0.1 mg tropomyosin 
without cholera toxin, 0.1 mg tropomyosin with cholera toxin and 1 mg 
. tropomyosin with cholera toxin. Data are expressed as mean 士 SE (n = 
5-14). * significant difference (P < 0.05; 1 -way ANOVA followed by Tukey 
test) from PBS control at the same week. 
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Figure 4.4 Passive cutaneous anaphylaxis on dermis of a naive 
mouse injected with pooled sera from different groups of mice. Injection 
‘ of saline served as control. Note significant vascular leakage in the areas 
where sera from mice fed with 0.1 mg or 1 mg tropomyosin with cholera 
toxin were injected. 
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4.3.4 Tropomyosin-specific cellular proliferation level of splenocytes 
When phytohemagglutinin (PHA) was used as a positive mitogen 
control, the stimulation indices ranged from 77.6 to 867.0 (data not shown). 
High level of indices indicated that the cells were healthy and they responded 
to mitogen stimulation. 
When tropomyosin was added to the culture as antigen, splenocytes 
from mice fed with 0.1 mg tropomyosin with adjuvant and 1 mg tropomyosin 
with adjuvant showed significant cellular proliferation with mean stimulation 
index of 20.1 and 12.7 respectively (Fig. 4.5). Significant cellular 
proliferation was also observed in mice fed with 0.1 mg tropomyosin without 
adjuvant (NT) with a mean stimulation index of 4.1. Splenocytes from mice 
fed with PBS, His-tag, and lysozyme showed no significant cellular 
proliferation. Mean stimulation indices of mice fed with PBS, His-tag, and 
lysozyme are 1.6, 2.3, and 2.7 respectively. 
When OVA was used as anitgen, all groups exhibited a stimulation 
index below 2. Altogether, data from splenocyte proliferation assay 
demonstrated that splenocytes from tropomyosin fed mice responded 
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Figure 4.5 Tropomyosin- and OVA-specific proliferative responses 
of splenocytes indifferent groups of mice (see Table 4.1 for abbreviations of 
the groups). Data are expressed mean 士 SE (n = 6-10). Cells cultured 
with phytohemagglutinin (PHA) serve as positive control (data not shown). 
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4.3.5 Cytokine profiles of splenocytes 
The level of four different types of cytokines, IL-2, IL-4, IL-10 and 
IFN- 7，were measured. When PHA was used as antigen, splenocytes 
produced high levels of all cytokines in the culture which indicated that the 
cells were healthy in producing cytokines. 
Statistical analysis showed that levels of IL-2 and IL-4 in mice fed 
with 0.1 mg tropomyosin with adjuvant were significantly higher than those 
in mice fed with PBS (Figs. 4.6 & 4.7). There are no significant differences 
in the levels between any other groups. When splenocytes of these two 
groups of mice were cultured in cell medium alone, no significant difference 
of IL-2 & IL-4 levels was found between different groups of mice. There 
is no significant difference in IFN- y level between different groups of mice 
when tropomyosin or cell medium alone was used (Fig. 4.8). When 
tropomyosin was added or cell medium was added alone, high levels of 
IL-10 were detected (Fig. 4.9). Yet there is no significant difference 
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Figure 4.6 Level of IL-2 produced from splenocytes in response to 
stimulation of tropomyosin in different groups of mice (see Table 4.1 for 
abbreviations of the groups). Splenocytes were cultured in culture medium 
in presence of tropomyosin, medium alone or PHA (data not shown). Data 
are expressed as mean 士 SE (n = 4-6). * significant difference (P < 0.001; 
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Figure 4.7 Level of IL-4 produced from splenocytes in response to 
stimulation of tropomyosin in different groups of mice (see Table 4.1 for 
abbreviations of the groups). Splenocytes were cultured in culture medium 
in presence of tropomyosin, medium alone (data not shown) or PHA (data 
not shown). Data are expressed as mean 土 SE (n = 4-6). * significant 
difference (P < 0.001; 1-way ANOVA followed by Tukey test) from PBS 
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Figure 4.8 Level of IFN-y produced from splenocytes in response to 
stimulation of tropomyosin in different groups of mice (see Table 4.1 for 
abbreviations of the groups). Splenocytes were cultured in culture medium 
in presence of tropomyosin, medium alone (data not shown) or PHA (data 
not shown). Data are expressed as mean 土 SE (n = 4-6). 
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Figure 4.9 Level of IL-10 produced from splenocytes in response to 
stimulation of tropomyosin in different groups of mice (see Table 4.1 for 
‘ abbreviations of the groups). Splenocytes were cultured in culture medium 
in presence of tropomyosin, medium alone (data not shown) or PHA (data 
not shown). Data are expressed as mean 士 SE (n = 4-6). 
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Table 4.2 Summary of levels of cytokines produced in different treatment 
groups of mice 
PBS His Lyso NT 0.1 mg 1 mg 
IL-2 L / / / . H L 
IL-4 / / / / H / 
IL-10 H H L H H H 
IFNy M M L L H H 
Key: 
H: high level 
M: medium level 
L: low level 
/: Very low level or nil 
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4.3.6 Histology of small intestines 
Infiltration of the lymphocytes in small intestine was observed in ‘ 
mice fed with 0.1 mg tropomyosin with adjuvant, 1 mg tropomyosin with 
adjuvant and 0.1 mg tropomyosin without adjuvant (Fig. 4.10). There were 
swelling of the submucosa in the small intestine with a large number of 
purple stained lymphocytes. Large areas of infiltration were observed in 
mice in the former two groups. The magnitude of inflammation was 
smaller in mice fed with 0.1 mg tropomyosin without adjuvant (NT) 
comparing with these two groups. Although small areas of infiltration of 
the lymphocytes were observed in some mice in control groups (data not 
shown), most of the control mice did not show infiltration. The magnitude 
and area of inflammation in control groups were very small. Generally 
speaking, the data demonstrated that inflammation of intestine was induced 
in mice fed with tropomyosin after challenge. 
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Figure 4.10 Histology of small intestine of mice after challenge. 
Infiltration of the lymphocytes were indicated by black arrows and observed 
in small intestine of mice fed with 1 mg tropomyosin (panel A), 0.1 mg 
tropomyosin (panel B) and 0.1 mg tropomyosin without adjuvant (panel C). 
No infiltration of the cells was found in mice fed with PBS (panel D), 








In the present study, a mouse model of shrimp allergy was 
successfully generated. The hypersensitivity responses of mice, including 
scratching behavior or changes in snout morphology were provoked by 
tropomyosin through oral sensitization. Scratching behavior represents one 
of the human seafood allergic responses which appears after ingestion of 
shrimp or other crustaceans. The swelling snout is similar to angioedema 
developed in some seafood allergy patients. Hsieh et al. (2003) 
demonstrated that feeding mice with peanut or OVA as food allergens 
respectively resulted in scratching behavior of mice after sensitization or 
challenge. Except scratching, mice also developed more serious 
anaphylactic responses, including wheezing, cyanosis around mouth and tail, 
no activity after prodding or even death after challenge. Comparing these 
results with the present study, mice in the present study only scratched 
around the body without cyanosis or even death. This may ascribe to the 
fact that the mice were sensitized epicutaneously or intraperitoneally in 
Hsieh et al. (2003) study rather than intragastrically as in the present study. 
Antigen-specific IgE is the one of the major indicators of food 
allergy as IgE antibody would initiate a series of food allergic reactions. 
The presence of high level of tropomyosin-specific IgE in sensitized mice 




Significantly high tropomyosin-specific IgE antibody was detected in mice 
fed with 0.1 mg tropomyosin with adjuvant after challenge at weeks four 
and five post-immunization. Interestingly, the level of IgE produced in 
mice fed with 0.1 mg tropomyosin with adjuvant was higher than that in 1 
mg, which is not significantly different from that in control mice. 
Preliminary study using a higher dose (2 mg) of recombinant tropomyosin 
with adjuvant showed that tropomyosin-specific IgE level was low (data not 
shown). As the IgE level in this group of mice increased from week four 
to five, it is believed that IgE level could be significant given a certain 
period of time. 
The relationship between dosage and the degree of hypersensitivity 
has been demonstrated in other studies. For example, Li et al. (2000) 
sensitized C3H/HeJ mice with 5 mg or 25 mg whole peanut and the mice 
fed with 5 mg whole peanut developed higher IgE level than those fed with 
25 mg whole peanut. The mice fed with 5 mg whole peanut also showed 
more anaphylactic responses. It seems that high concentration of allergens 
may result in oral tolerance rather than hypersensitivity. Chen and Weiner 
(1996) suggested that low dose of antigen induced activation of regulatory 
cells and high dose of antigen resulted in T cell anergy and clonal deletion. 
Strobel (1996) demonstrated that too high or too low concentration of 
allergen would result in low allergenicity or oral tolerance of the mice. 
The length of sensitization is also important in determining the level 
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of IgE antibody production. In the current study, sensitization period was 
limited to a short period of time (3 weeks). The rationale is that a short 
period of sensitization can prevent oral tolerance. Kjaer and Forkiaer 
(2002) found that the longer the feeding period of an allergen, the higher the 
chance the animals develop oral tolerance. 
It is also interesting that using the same dosage of tropomyosin (0.1 
mg), the immune responses of mice were different in the presence or 
absence of adjuvant. Different studies also demonstrated the effect of 
adjuvant in assisting IgE production (Woogen et al., 1987; Bromander et al., 
1991; Snider et al., 1994; Marinaro et al., 1995). For example, Snider et al. 
(1994) showed that mice sensitized with cholera toxin developed IgE level 
six times higher than those sensitized without cholera toxin. However, 
some researchers doubt the use of adjuvant in sensitization. Taylor and 
Lehrer (1996) suggested that mouse was an inappropiate species for the 
investigation of food allergy as it was difficult to elicit significant IgE 
antibody responses in the absence of suitable adjuvant. Houban et al. 
(1997) also worried that immunological tolerance nature of mice resulted 
from oral exposure to proteins would hamper the development of mice as a 
suitable model of food allergy. Therefore many researchers investigated 
oral tolerance to proteins in animals (e.g. Strobel and Mowat, 1998; Spahn 
et al., 2001). For example, Strobel and Mowat (1998) pointed out that "the 
development of systemic immunological hyporesponsiveness is only one of 
several possible outcomes that may result from oral exposure to proteins and 
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that the effective induction of tolerance is dependent upon a number of 
factors". Although there were possible concerns on the need of adjuvant 
and the possibility of induction of oral tolerance, the current study showed 
that the oral exposure of Balb/C mice to tropomyosin developed 
hypersensitivity responses. 
Passive cutaneous anaphylaxis (PCA) tests for the IgE availability in 
the sera. Dermis of a naive mouse receives sera from sensitized mice and 
IgE antibodies in sera would associate with the mast cells of the native 
mouse. Blue dye and tropomyosin injected together would form 
cross-linkage of antibody on the mast cells. Mast cells would release 
chemical mediators, e.g. histamine that cause vasodilation in the injection 
area. Such T cell response results in blue dye coming out from the blood 
vessels and blue color appears on the skin. In this study, blue spots were 
observed using sera from tropomyosin-sensitized mice (1 mg tropomyosin 
with adjuvant and 0.1 mg tropomyosin with adjuvant). Various studies 
employed PCA reported similar observation in animal models (Li et al., 
2000; Helm et al , 2002). For instance, Li et al. (2000) demonstrated 
positive results in PCA using sera from sensitized C3H/HeJ mice fed with 
peanut allergens. However, the positive result was eliminated when sera 
were heated. In the present study, both of the blue spots were greater than 
3 mm in diameter. However, blue spot produced by sera of mice fed with 
0.1 mg tropomyosin with adjuvant was larger than that with 1 mg 




IgE antibodies in the sera of mice fed with 0.1 mg tropomyosin with 
adjuvant. Sera from mice fed with tropomyosin without adjuvant (NT) did 
not give positive result in the present study. This is apparently due to the 
low level of IgE produced in this group. This result implies that there are 
strong co-relations between IgE-producing B cells with the 
cytokine-producing T cells in response to tropomyosin in the mice body. 
Marinaro et al. (1995) also demonstrated that none of the C57/BL6 mice 
showed positive results in PCA test in the absence of cholera toxin. They 
suggested that sufficient level of IgE was induced in the presence of cholera 
toxin which produced positive result in the PCA test. 
Tropomyosin would cause splenocytes of sensitized mice to 
proliferate and the proliferation level can reflect activity of lymphocytes 
towards tropomyosin. In this study, the stimulation index of mice fed with 
0.1 mg tropomyosin with adjuvant was higher than that in 1 mg tropomyosin. 
Li et al. (2000) also demonstrated that a lower concentration of antigen 
caused greater proliferation. Proliferation level of mice fed with 10 |j,g Ara 
h 1 was higher than that in 50 |4,g Ara h i . In the current study, splenocytes 
from mice fed with PBS, His-tag, or lysozyme showed low stimulation 
index indicating that tropomyosin was unable to stimulate cellular 
proliferation in control mice. This showed that splenocytes would only 




Cytokines play a major role in selecting the T cell pathway and 
isotype antibody produced during immune responses. Numerous studies 
have demonstrated that Th2 cytokines play a central role in pathogenesis of 
allergy disorders including food allergy (Bashir et al., 2002; Schade et al., 
2000). Understanding the cytokine profiles of shrimp allergic mice can 
reflect the cytokine profiles of seafood allergic patients which is informative 
in developing therapeutic treatment by suppression of allergic responses 
through cytokine regulation. In murine immune system, it is clear that 
activated Th2 cells would induce Th2 cytokines and IgE production, while 
activated Thl cells would induce Thl cytokines and IgG2a response. 
Street and Mosmann (1991) showed that activated Th 1 cells would produce 
IFN- r , IL-2 and TNF- /3，while activated Th 2 cells secreted IL-4, IL-5, 
IL-6 and IL-13. In the present study, four different cytokines IL-2, IL-4, 
IL-10, and IFN-y were chosen for detection. The reason of choosing IL-2 
is that IL-2 is a typical Thl cytokine (Abbas et al. 1996). IL-4 and IL-10 
indicate the activation of Th2 cells. IL-4 has pleotrophic actions that 
include the induction of FceRI expression (Ochi et al. 2000). It promotes 
the B cells to produce IgE (Romagnani, 2000) and is involved in endothelial 
and epithelial cell activation and mucus secretion in respiratory tract 
(Grunig et al., 1998). IL-10, a classical Th2 cytokine, has been recently 
suggested to be important in suppression of allergic inflammation (Barnes, 
2001). Marshall et al. (1996) showed that elevation in IL-10 level reduced 
TNF-a, and granulocyte-macrophage colony-stimulating factor (GM-CSF) 
production in mice. IFN-y inhibits Th2 cell activation and mast or basophil 
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,mediator release on re-exposure to antigen (Bissonnette and BefUs, 1990; 
Akdis et al., 2001; Morafo et al., 2003). The present study showed that 
there was no significant difference in IL-10 and IFN- y level among groups. 
This result suggested that IL-10 and IFN-y might play a less significant role 
in shrimp allergy responses. High level of IL-2 and IL-4 was found in the 
mice fed with 0.1 mg tropomyosin with adjuvant. While IL-2 level 
developed in these mice was 5 times above mice fed with PBS, IL-4 level 
in mice fed with 0.1 mg tropomyosin with adjuvant was 24 times higher 
than mice fed with PBS. This suggests that in a mixed Thl/Th2 response 
in the allergic mice. Compared with magnitude of cytokine production 
above the control (mice fed with PBS), mice fed with 0.1 mg tropomyosin 
with adjuvant developed much higher IL-4 level than those in IL-2 level, 
suggesting that Th2-type profile was predominant in vivo in mice 
immunized orally. This suggestion was also supported by Schade et al. 
(2000) who demonstrated that T cell clones generated cow milk-allergic 
infants released high levels of IL-4, IL-5, and IL-13, and low level of IFN-
7，whereas cells from infants without food allergy released high levels of 
IFN- 7 and low levels of IL-4, IL-5, and IL-13. Further work is needed to 
determine whether other cytokines (e.g. IL-5, IL-13) are key cytokines in 
shrimp allergy of mice. 
Food allergy is generally believed to be the result of change in the 
permeability of gastrointestinal tract. Histological changes of the organs 
provide us an important evidence of food allergy. Mice fed with 
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tropomyosin with or without adjuvant showed different degrees of 
infiltration of lymphocytes. Mice fed with 0.1 mg tropomyosin with 
adjuvant exhibited the strongest inflammation among the groups, followed 
by 1 mg tropomyosin with adjuvant and 0.1 mg tropomyosin without 
adjuvant. This provides strong evidence that the mice experienced 
allergenic shock. Constituent findings were always reported in studies 
(Ohtsuka et al., 1998; Kweon et al., 2000). Previous studies showed 
localized infiltration of eosinophils in the intestine of induced mice upon 
oral antigen exposure. Ermel et al. (1997) demonstrated gastric 
submucosal epithelial vascuolar degeneration, periglandular edema, 
infiltration of neurtophils and eosinophils in atopic dogs using wheat and 
milk. Large areas of inflammation in the gastrointestinal tracts of the 
atopic dog were also observed through endoscope. Hsieh et al. (2003) 
even found mucosal vascular congestion in small intestine and lung 
inflammation in Balb/C mice. Clusters of red blood cells were found in the 
congested capillaries. Lung sections revealed inflammations of the 
alveolar with great infiltration of lymphocytes. 
Further work with this model will focus on the development of 
therapeutic strategy using DNA vaccine for treatment of seafood allergy. 
DNA vaccine was shown to be effective for treatment of various diseases 
including allergy (Nguyen et al.，2001; Romana et al., 2003). Recently, the 
major epitopes of shrimp Penaeus aztecus tropomyosin were identified by 




investigation today are based on the knowledge of the amino acid sequences 
in the IgE-reactive B-cell epitopes (van Neerven, 1999). These epitopes 
provide important information on the design of DNA vaccine. Major 
IgE-binding epitope sequences can be inserted into mammalian expression 
vector for the production of vaccine. The vaccine can produce endogenous 






In summary, a mouse model of shrimp allergy was successfully 
developed. Tropomyosin-specific IgE was induced and hypersensitive 
responses were also provoked by orally feeding of tropomyosin. 
Splenocytes proliferated specifically in response to tropomyosin and 
exhibited Th2 responses through cytokine production. Passive cutaneous 
anaphylaxis assay was found to be positive using sera of mice fed with 
tropomyosin. Infiltrations of lymphocytes in small intestines were 
observed in mice after challenged by tropomyosin. Oral sensitization of 
mice with recombinant shrimp tropomyosin could induce antigen specific 
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